<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JAMA Netw Open</journal-id><journal-id journal-id-type="iso-abbrev">JAMA Netw Open</journal-id><journal-title-group><journal-title>JAMA Network Open</journal-title></journal-title-group><issn pub-type="epub">2574-3805</issn><publisher><publisher-name>American Medical Association</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39998832</article-id><article-id pub-id-type="pmc">PMC11862973</article-id>
<article-id pub-id-type="doi">10.1001/jamanetworkopen.2024.61559</article-id><article-id pub-id-type="publisher-id">zoi241712</article-id><article-categories><subj-group subj-group-type="category" specific-use="electronic"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group><subj-group subj-group-type="online-only"><subject>Online Only</subject></subj-group><subj-group subj-group-type="subject-area"><subject>Psychiatry</subject></subj-group></article-categories><title-group><article-title>Suicide Risk Evaluations and Suicide in the Veterans Health Administration</article-title><alt-title alt-title-type="headline">Suicide Risk Evaluations and Suicide in the Veterans Health Administration</alt-title><alt-title alt-title-type="running-head">Suicide Risk Evaluations and Suicide in the Veterans Health Administration</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Saulnier</surname><given-names>Kevin G.</given-names></name><degrees>PhD</degrees><xref rid="zoi241712aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="zoi241712aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="zoi241712aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bagge</surname><given-names>Courtney L.</given-names></name><degrees>PhD</degrees><xref rid="zoi241712aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="zoi241712aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ganoczy</surname><given-names>Dara</given-names></name><degrees>MPH</degrees><xref rid="zoi241712aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bahraini</surname><given-names>Nazanin H.</given-names></name><degrees>PhD</degrees><xref rid="zoi241712aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="zoi241712aff5" ref-type="aff">
<sup>5</sup>
</xref><xref rid="zoi241712aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Jagusch</surname><given-names>Jennifer</given-names></name><degrees>MSW</degrees><xref rid="zoi241712aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="zoi241712aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hosanagar</surname><given-names>Avinash</given-names></name><degrees>MD</degrees><xref rid="zoi241712aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="zoi241712aff7" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ilgen</surname><given-names>Mark A.</given-names></name><degrees>PhD</degrees><xref rid="zoi241712aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="zoi241712aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Pfeiffer</surname><given-names>Paul N.</given-names></name><degrees>MD</degrees><xref rid="zoi241712aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="zoi241712aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="zoi241712aff1"><label>1</label>Veterans Affairs (VA) Serious Mental Illness Treatment Resource and Evaluation Center, Office of Mental Health, Ann Arbor, Michigan</aff><aff id="zoi241712aff2"><label>2</label>Department of Psychiatry, University of Michigan, Ann Arbor</aff><aff id="zoi241712aff3"><label>3</label>VA Center for Clinical Management Research, Health Systems Research, Ann Arbor, Michigan</aff><aff id="zoi241712aff4"><label>4</label>VA Rocky Mountain Mental Illness Research, Education, and Clinical Center for Suicide Prevention, Aurora, Colorado</aff><aff id="zoi241712aff5"><label>5</label>Department of Physical Medicine and Rehabilitation, Anschutz Medical Campus, University of Colorado, Aurora</aff><aff id="zoi241712aff6"><label>6</label>Department of Psychiatry, Anschutz Medical Campus, University of Colorado, Aurora</aff><aff id="zoi241712aff7"><label>7</label>Ann Arbor VA Healthcare System, Ann Arbor, Michigan</aff><author-notes><title>Article Information</title><p><bold>Accepted for Publication:</bold> December 3, 2024.</p><p content-type="published-online"><bold>Published:</bold> February 25, 2025. doi:<uri content-type="doi">10.1001/jamanetworkopen.2024.61559</uri></p><p content-type="open-access-note"><bold>Open Access:</bold> This is an open access article distributed under the terms of the <ext-link xlink:href="https://jamanetwork.com/pages/cc-by-license-permissions" ext-link-type="uri">CC-BY License</ext-link>. &#x000a9; 2025 Saulnier KG et al. <italic>JAMA Network Open</italic>.</p><corresp id="zoi241712cor1"><bold>Corresponding Author:</bold> Kevin G. Saulnier, PhD, Department of Psychiatry, University of Michigan, Ann Arbor, MI 48109 (<email xlink:href="kesaulni@med.umich.edu">kesaulni@med.umich.edu</email>).</corresp><p content-type="author-contributions"><bold>Author Contributions:</bold> Ms Ganoczy had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p><p><italic>Concept and design:</italic> Saulnier, Bagge, Pfeiffer.</p><p><italic>Acquisition, analysis, or interpretation of data:</italic> Bagge, Ganoczy, Bahraini, Jagusch, Hosanagar, Ilgen, Pfeiffer.</p><p><italic>Drafting of the manuscript:</italic> Saulnier, Hosanagar, Pfeiffer.</p><p><italic>Critical review of the manuscript for important intellectual content:</italic> Bagge, Ganoczy, Bahraini, Jagusch, Hosanagar, Ilgen, Pfeiffer.</p><p><italic>Statistical analysis:</italic> Saulnier, Ganoczy.</p><p><italic>Administrative, technical, or material support:</italic> Jagusch.</p><p><italic>Supervision:</italic> Saulnier, Bagge, Ilgen, Pfeiffer.</p><p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Hosanagar reported being a co&#x02013;investigator in a research study on psilocybin in treatment-resistant depression sponsored by Compass Pathways, outside the submitted work. No other disclosures were reported.</p><p><bold>Disclaimer:</bold> Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by, or represent, the views of the Department of Veterans Affairs or the US Government.</p><p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-ZOI241712-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p></author-notes><pub-date pub-type="epub" iso-8601-date="2025-02-25T10:00"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>2</month><year>2025</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>8</volume><issue>2</issue><elocation-id>e2461559</elocation-id><history><date date-type="received"><day>24</day><month>9</month><year>2024</year></date><date date-type="accepted"><day>3</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>Copyright 2025 Saulnier KG et al. <italic>JAMA Network Open</italic>.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the CC-BY License.</license-p></license></permissions><self-uri content-type="pdf-version" xlink:href="jamanetwopen-e2461559.pdf">jamanetwopen-e2461559.pdf</self-uri><self-uri content-type="silverchair" xlink:href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.61559"/><related-article related-article-type="commentary" ext-link-type="doi" id="ZIC240380" xlink:href="10.1001/jamanetworkopen.2024.61564"/><abstract abstract-type="key-points"><title>Key Points</title><sec id="ab-zoi241712-1"><title>Question</title><p>Which elements of the nationally standardized Veterans Health Administration (VHA) Comprehensive Suicide Risk Evaluation (CSRE) are associated with subsequent suicide?</p></sec><sec id="ab-zoi241712-2"><title>Findings</title><p>In this cohort study, of the 269&#x02009;374 CSREs completed by 153&#x02009;736 VHA patients, suicidal ideation, firearm access, and preparatory behaviors were associated with acute (within 30 days) and chronic (within 365 days) suicide risk. In adjusted models, no protective factors (eg, hope, social support) in the CSRE were associated with acute or chronic suicide risk.</p></sec><sec id="ab-zoi241712-3"><title>Meaning</title><p>Findings suggest that VHA clinicians would benefit from a particular focus on a subset of CSRE responses, and that developing risk prediction algorithms may enhance clinical evaluations of suicide risk.</p></sec></abstract><abstract><sec id="ab-zoi241712-4"><title>Importance</title><p>The Veterans Health Administration (VHA) implemented the Comprehensive Suicide Risk Evaluation (CSRE) in 2019 to standardize suicide risk assessment across the health care system. Identifying CSRE responses associated with suicide could inform risk management and prevent suicide.</p></sec><sec id="ab-zoi241712-5"><title>Objective</title><p>To identify CSRE responses associated with subsequent suicide.</p></sec><sec id="ab-zoi241712-6"><title>Design, Setting, and Participants</title><p>This cohort study examines acute (within 30 days) and chronic (within 365 days) suicide risk after 269 374 CSREs were administered. Participants included US VHA patients undergoing CSRE evaluation between November 1, 2019, and December 31, 2020. Data collection and analysis were performed from April 5 to August 20, 2024.</p></sec><sec id="ab-zoi241712-7"><title>Exposures</title><p>CSRE responses, including suicidal ideation, behaviors, warning signs, risk factors, and protective factors.</p></sec><sec id="ab-zoi241712-8"><title>Main Outcome and Measure</title><p>Suicide per death certificate data from the Department of Veterans Affairs and Department of Defense Mortality Data Repository. Outcomes were analyzed using multivariable Cox proportional hazards regression.</p></sec><sec id="ab-zoi241712-9"><title>Results</title><p>A total of 153&#x02009;736 patients with 269 374 valid CSREs (86.26% male; mean [SD] age,&#x02009;50.48 [15.26] years) were included in the multivariable-adjusted analyses of suicide. Suicidal ideation (hazard ratio [HR],&#x02009;3.14; 95% CI,&#x02009;1.51-6.54), firearm access (HR,&#x02009;2.62; 95% CI,&#x02009;1.49-4.61), making preparations for a suicide attempt (HR,&#x02009;2.15; 95% CI,&#x02009;1.27-3.62), seeking access to lethal means (HR,&#x02009;2.04; 95% CI,&#x02009;1.11-3.75), anxiety (HR,&#x02009;1.80; 95% CI,&#x02009;1.16-2.81), and psychiatric hospitalization history (HR,&#x02009;1.63; 95% CI,&#x02009;1.02-2.61) were associated with increased suicide risk within 30 days, whereas anger (HR,&#x02009;0.50; 95% CI,&#x02009;0.30-0.85) was associated with decreased risk. Suicidal ideation (HR,&#x02009;1.63; 95% CI,&#x02009;1.20-2.21), firearm access (HR,&#x02009;1.55; 95% CI,&#x02009;1.13-2.13), making preparations for a suicide attempt (HR,&#x02009;1.56; 95% CI,&#x02009;1.09-2.23), reckless behaviors (HR,&#x02009;1.40; 95% CI,&#x02009;1.00-1.95), and history of psychiatric hospitalization (HR,&#x02009;1.68; 95% CI,&#x02009;1.32-2.13) were associated with increased suicide risk within 365 days, whereas anger (HR,&#x02009;0.56; 95% CI,&#x02009;0.44-0.71), preexisting risk factors (eg, trauma; HR,&#x02009;0.77; 95% CI,&#x02009;0.62-0.96), and recent transition from the military (HR,&#x02009;0.39; 95% CI,&#x02009;0.22-0.70) were associated with decreased risk in multivariable-adjusted analyses. Suicide risk within 365 days was elevated among patients identified by clinicians to be at intermediate acute risk (HR,&#x02009;1.39; 95% CI,&#x02009;1.13-1.71), intermediate chronic risk (HR,&#x02009;1.34; 95% CI,&#x02009;1.01-1.77), and high chronic risk (HR,&#x02009;1.74; 95% CI,&#x02009;1.22-2.47) of suicide compared with patients at low risk in multivariable-adjusted analyses.</p></sec><sec id="ab-zoi241712-10"><title>Conclusions and Relevance</title><p>In this cohort study of suicide following risk assessments, findings suggest that only a few constructs are associated with subsequent suicide, particularly suicidal ideation, firearm access, and preparatory behaviors. Developing risk prediction algorithms including CSRE responses may enhance clinical evaluation.</p></sec></abstract><abstract abstract-type="teaser" specific-use="electronic"><p>This cohort study evaluates the association of Comprehensive Suicide Risk Evaluation responses with suicide in a large, national cohort of patients evaluated within the Veterans Health Administration.</p></abstract></article-meta></front><body><sec id="H1-1-ZOI241712"><title>Introduction</title><p>The age- and sex-adjusted suicide rate among US veterans increased by 76.3% from 2001 to 2021.<sup><xref rid="zoi241712r1" ref-type="bibr">1</xref></sup> Suicide prevention is the top clinical priority of the Department of Veterans Affairs (VA),<sup><xref rid="zoi241712r2" ref-type="bibr">2</xref></sup> and improving suicide risk detection among patients treated in the Veterans Health Administration (VHA) is a key component of a comprehensive approach to reducing suicide.<sup><xref rid="zoi241712r3" ref-type="bibr">3</xref></sup></p><p>The VHA implemented Risk ID, a standardized procedure for systemwide suicide screening and risk assessment, in 2018.<sup><xref rid="zoi241712r4" ref-type="bibr">4</xref></sup> The current version of Risk ID mandates that VHA patients receive annual suicide screening via the Columbia Suicide Severity Rating Scale (C-SSRS).<sup><xref rid="zoi241712r5" ref-type="bibr">5</xref></sup> Clinical reminders are integrated into the VHA electronic health record to notify clinicians when the screen is due. When a patient reports thinking about how they would attempt suicide in the past month or suicidal behavior in the prior 3 months (ie, positive screens), a licensed independent clinician is required to conduct the VHA&#x02019;s Comprehensive Suicide Risk Evaluation (CSRE) to further assess suicidal ideation and behavior, suicide warning signs, risk factors, and protective factors.<sup><xref rid="zoi241712r6" ref-type="bibr">6</xref></sup> On the CSRE, warning signs signal an acute increase in risk of suicidal behavior in the immediate future. CSRE requirements are consistent across clinical settings, such that mental health and non&#x02013;mental health clinicians may complete the CSRE. The CSRE can also be administered without first completing a C-SSRS. For example, mental health clinicians may routinely administer the CSRE as part of evaluations. Despite the national adoption of the CSRE, no study, to our knowledge, has examined the prospective associations between CSRE responses and suicide.</p><p>The CSRE was developed to include evidence-based factors associated with suicide<sup><xref rid="zoi241712r6" ref-type="bibr">6</xref></sup> as reflected by the VA&#x02013;Department of Defense (DoD) Clinical Practice Guidelines<sup><xref rid="zoi241712r4" ref-type="bibr">4</xref></sup> and The Joint Commission&#x02019;s National Patient Safety Goal, version 15.01.01.<sup><xref rid="zoi241712r7" ref-type="bibr">7</xref></sup> Although training materials are available, the CSRE is not a structured interview and does not provide question prompts. Based on their assessment, clinicians place patients in high-, intermediate-, or low-risk strata for acute and chronic suicide risk. Identifying CSRE responses associated with subsequent suicide could inform evidence-based suicide risk determinations. Establishing the incremental value of the CSRE after accounting for demographic and diagnostic risk factors within the clinical record may also inform current practices.</p><p>This study evaluated suicide in association with CSRE responses in a large national cohort of VHA patients, after adjusting for demographic factors and mental health diagnoses. Our primary analyses examined acute (within 30 days after CSRE administration) and chronic (within 365 days after CSRE administration) suicide risk.</p></sec><sec id="H1-2-ZOI241712"><title>Methods</title><p>This population-based cohort study was conducted using methods approved by the Ann Arbor VA&#x02019;s Institutional Review Board and under a waiver of informed consent. We followed Strengthening the Reporting of Observational Studies in Epidemiology (<ext-link xlink:href="http://www.equator-network.org/reporting-guidelines/strobe/" ext-link-type="uri">STROBE</ext-link>) guidelines for reporting cohort studies. Data collection and analysis were conducted from April 5 to August 20, 2024.</p><sec id="H2-1-ZOI241712"><title>Data Sources</title><p>The VHA Corporate Data Warehouse (CDW) was used to obtain demographic and clinical information. Vital status and cause of death were obtained via the VA-DoD Mortality Data Repository.<sup><xref rid="zoi241712r8" ref-type="bibr">8</xref></sup></p></sec><sec id="H2-2-ZOI241712"><title>Cohort</title><p>Completed CSREs recorded in VHA records from November 1, 2019, through December 31, 2020, were included. November 1, 2019, was the initial inclusion date given the CSRE was implemented nationally on that date.<sup><xref rid="zoi241712r6" ref-type="bibr">6</xref></sup> Analyses treated CSREs as the unit of analysis, allowing VHA patients to have multiple evaluations. CSREs marked as invalid by the clinician and CSREs that were documented on or after the date of death were excluded.</p></sec><sec id="H2-3-ZOI241712"><title>Measures</title><sec id="H3-1-ZOI241712"><title>CSRE</title><p>The CSRE is a tool that specifies constructs for clinicians to use during suicide risk assessments. The CSRE includes 5 suicidal ideation, behavior, and lethal means items (ie, suicidal ideation, firearm access, nonfirearm lethal means access, prior suicide attempts, preparatory behavior), as well as 12 warning signs (eg, hopelessness), 12 risk factors (eg, recent losses), and 14 protective factors (eg, social support). CSRE items are scored on a binary presence or absence scale, with suicide-related items also including an option of unknown (combined with absence for these analyses). The CSRE does not include question prompts. Using clinical judgment, clinicians place patients in low-, intermediate-, and high-risk strata for acute and chronic suicide risk. CSRE responses are stored as health factors in the CDW.</p></sec><sec id="H3-2-ZOI241712"><title>C-SSRS Screen</title><p>The C-SSRS is a clinician-administered assessment that screens for suicidal ideation, planning, and behavior.<sup><xref rid="zoi241712r5" ref-type="bibr">5</xref></sup> Items are scored on a binary yes or no scale. In the VHA, thinking about how to make a suicide attempt in the past month and/or suicidal behavior within the past 3 months are positive screen indications. CSREs completed within 2 days of a C-SSRS (ie, those likely conducted following VA&#x02019;s Risk ID protocols) were examined in a supplemental analysis. C-SSRS item responses were not included in these models.</p></sec><sec id="H3-3-ZOI241712"><title>Suicide Mortality</title><p>Suicides were identified by queries of the VA-DoD Mortality Data Repository, which includes results from annual VA-DoD searches of death certificates from the Centers for Disease Control and Prevention National Death Index.<sup><xref rid="zoi241712r8" ref-type="bibr">8</xref></sup>
<italic>International Statistical Classification of Diseases, Tenth Revision</italic>,<sup><xref rid="zoi241712r9" ref-type="bibr">9</xref></sup> cause of death codes used to identify suicides included U03, X60 to X84, and Y87.0.</p></sec><sec id="H3-4-ZOI241712"><title>Covariates</title><p>Demographic factors identified via CDW based on prior VHA suicide studies<sup><xref rid="zoi241712r1" ref-type="bibr">1</xref></sup> included age, biological sex, race (American Indian or Alaska Native, Asian, Black, Native Hawaiian or Other Pacific Islander, White, multiracial, or unknown), ethnicity (Hispanic or non-Hispanic), and service connection. Psychiatric diagnoses were identified in the 365 days prior to CSRE administration. We also included the setting in which the CSRE was completed, categorized into emergency department, inpatient psychiatric, inpatient nonpsychiatric, outpatient mental health, outpatient non&#x02013;mental health (eg, specialty medicine, non&#x02013;mental health social work, urgent care), primary care, and primary care&#x02013;mental health integration. The setting where the CSRE was completed may differ from the screening setting, as patients may be transferred from medicine clinics to mental health clinics to complete the CSRE.</p></sec></sec><sec id="H2-4-ZOI241712"><title>Statistical Analysis</title><p>Analyses were conducted in SAS Enterprise, version 9.4.<sup><xref rid="zoi241712r10" ref-type="bibr">10</xref></sup> Bivariate associations between study constructs and suicide in the 30 and 365 days following CSRE administration were examined. Next, multivariable Cox proportional hazards regression models were estimated, with risk time beginning the day following CSRE administration. Analyses adjusted for the clustering of CSREs within patients, allowing patients to contribute overlapping risk time for multiple CSREs, consistent with other VHA examinations.<sup><xref rid="zoi241712r11" ref-type="bibr">11</xref>,<xref rid="zoi241712r12" ref-type="bibr">12</xref></sup> Multicollinearity diagnostics were examined, with correlation coefficients of 0.80 or greater, variance inflation factor values of 2.50 or greater, and tolerance values of 0.20 or less indicating problematic multicollinearity.<sup><xref rid="zoi241712r13" ref-type="bibr">13</xref></sup></p><p>Two Cox proportional hazards regression models examined the associations between CSRE responses and suicide. In the analysis of acute suicide risk, risk time continued for 30 days after CSRE administration or until death, whichever occurred first. Risk time for chronic suicide risk continued for 365 days or until death, whichever occurred first. Models were generated with and without clinician-determined risk strata. In the models without clinician-determined risk strata, the only substantive change was the hazard ratio (HR) for preexisting risk factors to 0.78 from 0.77, meaning it no longer met criteria for being statistically and clinically significant. We present the models with clinician-determined risk strata in the main text and models without clinician-determined risk strata in eTable 1 in <xref rid="note-ZOI241712-1-s" ref-type="supplementary-material">Supplement 1</xref>.</p><p>Sensitivity analyses examined associations between CSRE responses and suicide for initial CSREs and for CSREs within 2 days of a positive C-SSRS screen (see eTables 2 and 3 in <xref rid="note-ZOI241712-1-s" ref-type="supplementary-material">Supplement 1</xref>, respectively). We considered effect estimates to be statistically and clinically significant if HRs were 0.77 or less or 1.30 or greater with a 2-sided <italic>P</italic>&#x02009;&#x02264;&#x02009;.05.<sup><xref rid="zoi241712r14" ref-type="bibr">14</xref></sup></p></sec></sec><sec id="H1-3-ZOI241712"><title>Results</title><p>A total of 272&#x02009;335 CSREs were completed from November 1, 2019, to December 31, 2020, with 269&#x02009;374 (98.91%) marked valid and included in analyses (including 153&#x02009;736 unique VHA patients). This includes 138 invalid CSREs that were completed on the same day as an invalid CSRE. Among the 269 374 CSREs, 86.26% were for male and 13.74% for female patients; 24.69% were for Black and 63.54% for White patients, with 7.22% of unknown race; and the mean (SD) age was 50.48 (15.26) years. Most patients completed a single CSRE during the period of interest (103 424 [67.27%]; 50&#x02009;312 patients completed &#x0003e;1 CSRE; mean [SD] No. of CSREs,&#x02009;1.75&#x02009;[1.82]). Overall, 9107 CSREs (3.38%) were completed by individuals who died within 365 days of CSRE administration (mean [SD] risk time,&#x02009;358.66 [39.01] days; median,&#x02009;365.00 [1-365] days; total risk time,&#x02009;96&#x02009;613&#x02009;410.00 days), with 791 CSREs (0.29%) completed by 385 individuals who died by suicide. The unadjusted suicide rate per 100&#x02009;000 person-years following an initial CSRE was 228.92 (95% CI, 205.43-253.66). Bivariate associations between suicide and covariates can be found in <xref rid="zoi241712t1" ref-type="table">Table 1</xref>. In bivariate analyses, 24 of the 43 CSRE constructs (55.81%) were associated with suicide within 30 or 365 days, with 10 of the 43 CSRE responses (23.26%) associated with suicide within 30 days after the CSRE, and 23 (53.49%) were associated with suicide within 365 days (<xref rid="zoi241712t2" ref-type="table">Table 2</xref>). Patients at high acute risk (as identified by their clinician) were at greater suicide risk within 30 days (HR,&#x02009;3.21; 95% CI, 1.99-5.17; <italic>P</italic>&#x02009;&#x0003c;&#x02009;.001) and 365 days (HR,&#x02009;2.72; 95% CI, 2.14-3.46; <italic>P</italic>&#x02009;&#x0003c;&#x02009;.001) compared with patients at low acute risk, and patients at high chronic risk were at greater suicide risk within 30 days (HR,&#x02009;3.82; 95% CI, 2.16-6.73; <italic>P</italic>&#x02009;&#x0003c;&#x02009;.001) and 365 days (HR,&#x02009;3.89; 95% CI, 2.92-5.19; <italic>P</italic>&#x02009;&#x0003c;&#x02009;.001), compared with patients at low chronic risk. However, 172 CSREs for 133 unique suicide decedents were assessed as being at low acute and low chronic risk. We also examined clinician-determined acute and chronic risk strata combinations, finding that patients with low acute and low chronic risks had the lowest subsequent suicide risk. Suicide risk increased with each tier of clinician-determined risk strata (eTable 4 in <xref rid="note-ZOI241712-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p><table-wrap position="float" id="zoi241712t1"><label>Table 1. </label><caption><title>Demographic and Psychiatric Diagnosis Characteristics<xref rid="zoi241712t1n1" ref-type="table-fn"><sup>a</sup></xref></title></caption><table frame="hsides" rules="groups"><col width="15.39%" span="1"/><col width="8.97%" span="1"/><col width="13.46%" span="1"/><col width="13.46%" span="1"/><col width="6.41%" span="1"/><col width="10.9%" span="1"/><col width="12.18%" span="1"/><col width="13.46%" span="1"/><col width="5.77%" span="1"/><thead><tr><th rowspan="3" valign="top" align="left" scope="col" colspan="1">Variable</th><th colspan="4" valign="top" align="left" scope="colgroup" rowspan="1">Suicide within 30 d</th><th colspan="4" valign="top" align="left" scope="colgroup" rowspan="1">Suicide within 365 d</th></tr><tr><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">No. (%) of CSREs</th><th rowspan="2" valign="top" align="left" scope="col" colspan="1">HR (95% CI)</th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"><italic>P</italic> value</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">No. (%) of CSREs</th><th rowspan="2" valign="top" align="left" scope="col" colspan="1">HR (95% CI)</th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"><italic>P</italic> value</th></tr><tr><th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Present (n&#x02009;=&#x02009;144)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Absent (n&#x02009;=&#x02009;269&#x02009;230)</th><th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Present (n&#x02009;=&#x02009;791)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Absent (n&#x02009;=&#x02009;268&#x02009;583)</th></tr></thead><tbody><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Age, y</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 18-34</td><td valign="top" align="left" rowspan="1" colspan="1">22 (15.28)</td><td valign="top" align="left" rowspan="1" colspan="1">51&#x02009;445 (19.11)</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">193 (24.40)</td><td valign="top" align="left" rowspan="1" colspan="1">51&#x02009;274 (19.09)</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 35-54</td><td valign="top" align="left" rowspan="1" colspan="1">55 (38.19)</td><td valign="top" align="left" rowspan="1" colspan="1">99&#x02009;474 (36.95)</td><td valign="top" align="left" rowspan="1" colspan="1">1.29 (0.59-2.82)</td><td valign="top" align="left" rowspan="1" colspan="1">.52</td><td valign="top" align="left" rowspan="1" colspan="1">284 (35.90)</td><td valign="top" align="left" rowspan="1" colspan="1">99&#x02009;245 (36.95)</td><td valign="top" align="left" rowspan="1" colspan="1">0.76 (0.55-1.06)</td><td valign="top" align="left" rowspan="1" colspan="1">.11</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &#x02265;55</td><td valign="top" align="left" rowspan="1" colspan="1">67 (46.53)</td><td valign="top" align="left" rowspan="1" colspan="1">118&#x02009;309 (43.94)</td><td valign="top" align="left" rowspan="1" colspan="1">1.33 (0.63-2.78)</td><td valign="top" align="left" rowspan="1" colspan="1">.46</td><td valign="top" align="left" rowspan="1" colspan="1">314 (39.70)</td><td valign="top" align="left" rowspan="1" colspan="1">118&#x02009;062 (43.96)</td><td valign="top" align="left" rowspan="1" colspan="1">0.72 (0.51-1.03)</td><td valign="top" align="left" rowspan="1" colspan="1">.07</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Sex</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Female</td><td valign="top" align="left" rowspan="1" colspan="1">19 (13.19)</td><td valign="top" align="left" rowspan="1" colspan="1">36&#x02009;982 (13.74)</td><td valign="top" align="left" rowspan="1" colspan="1">0.96 (0.41-2.21)</td><td valign="top" align="left" rowspan="1" colspan="1">.91</td><td valign="top" align="left" rowspan="1" colspan="1">73 (9.23)</td><td valign="top" align="left" rowspan="1" colspan="1">36&#x02009;928 (13.75)</td><td valign="top" align="left" rowspan="1" colspan="1">0.63 (0.41-0.99)</td><td valign="top" align="left" rowspan="1" colspan="1">.04</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Male</td><td valign="top" align="left" rowspan="1" colspan="1">125 (86.81)</td><td valign="top" align="left" rowspan="1" colspan="1">232&#x02009;248 (86.26)</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">718 (90.77)</td><td valign="top" align="left" rowspan="1" colspan="1">231&#x02009;655 (86.25)</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Race</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> American Indian or Alaska Native</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Asian</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Black</td><td valign="top" align="left" rowspan="1" colspan="1">10 (6.94)</td><td valign="top" align="left" rowspan="1" colspan="1">66&#x02009;485 (24.69)</td><td valign="top" align="left" rowspan="1" colspan="1">0.23 (0.11-0.51)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">50 (6.32)</td><td valign="top" align="left" rowspan="1" colspan="1">66&#x02009;445 (24.74)</td><td valign="top" align="left" rowspan="1" colspan="1">0.20 (0.13-0.30)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Native Hawaiian or Other Pacific Islander</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> White</td><td valign="top" align="left" rowspan="1" colspan="1">110 (76.39)</td><td valign="top" align="left" rowspan="1" colspan="1">171&#x02009;077 (63.54)</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">651 (82.30)</td><td valign="top" align="left" rowspan="1" colspan="1">170&#x02009;536 (63.49)</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Multiracial</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Unknown</td><td valign="top" align="left" rowspan="1" colspan="1">17 (11.81)</td><td valign="top" align="left" rowspan="1" colspan="1">19&#x02009;444 (7.22)</td><td valign="top" align="left" rowspan="1" colspan="1">1.36 (0.67-2.77)</td><td valign="top" align="left" rowspan="1" colspan="1">.40</td><td valign="top" align="left" rowspan="1" colspan="1">51 (6.45)</td><td valign="top" align="left" rowspan="1" colspan="1">19&#x02009;410 (7.23)</td><td valign="top" align="left" rowspan="1" colspan="1">0.69 (0.44-1.07)</td><td valign="top" align="left" rowspan="1" colspan="1">.10</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hispanic ethnicity</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">52 (6.57)</td><td valign="top" align="left" rowspan="1" colspan="1">22&#x02009;288 (8.30)</td><td valign="top" align="left" rowspan="1" colspan="1">0.77 (0.47-1.28)</td><td valign="top" align="left" rowspan="1" colspan="1">.31</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Service connected</td><td valign="top" align="left" rowspan="1" colspan="1">66 (45.83)</td><td valign="top" align="left" rowspan="1" colspan="1">198&#x02009;271 (73.64)</td><td valign="top" align="left" rowspan="1" colspan="1">0.30 (0.19-0.49)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">454 (57.40)</td><td valign="top" align="left" rowspan="1" colspan="1">197&#x02009;883 (73.68)</td><td valign="top" align="left" rowspan="1" colspan="1">0.48 (0.36-0.63)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">CSRE setting</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> ED</td><td valign="top" align="left" rowspan="1" colspan="1">12 (8.33)</td><td valign="top" align="left" rowspan="1" colspan="1">11&#x02009;891 (4.42)</td><td valign="top" align="left" rowspan="1" colspan="1">2.07 (1.05-4.07)</td><td valign="top" align="left" rowspan="1" colspan="1">.04</td><td valign="top" align="left" rowspan="1" colspan="1">50 (6.32)</td><td valign="top" align="left" rowspan="1" colspan="1">11&#x02009;853 (4.41)</td><td valign="top" align="left" rowspan="1" colspan="1">1.54 (1.13-2.10)</td><td valign="top" align="left" rowspan="1" colspan="1">.007</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> IP MH</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> IP non-MH</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> OP MH</td><td valign="top" align="left" rowspan="1" colspan="1">98 (68.06)</td><td valign="top" align="left" rowspan="1" colspan="1">200&#x02009;485 (74.47)</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">553 (69.91)</td><td valign="top" align="left" rowspan="1" colspan="1">200&#x02009;030 (74.48)</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> OP non-MH</td><td valign="top" align="left" rowspan="1" colspan="1">30 (20.83)</td><td valign="top" align="left" rowspan="1" colspan="1">44&#x02009;997 (16.71)</td><td valign="top" align="left" rowspan="1" colspan="1">1.37 (0.88-2.12)</td><td valign="top" align="left" rowspan="1" colspan="1">.17</td><td valign="top" align="left" rowspan="1" colspan="1">158 (19.97)</td><td valign="top" align="left" rowspan="1" colspan="1">44&#x02009;869 (16.71)</td><td valign="top" align="left" rowspan="1" colspan="1">1.28 (1.02-1.62)</td><td valign="top" align="left" rowspan="1" colspan="1">.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Primary care</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> PCMHI</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">14 (1.77)</td><td valign="top" align="left" rowspan="1" colspan="1">8050 (3.00)</td><td valign="top" align="left" rowspan="1" colspan="1">0.63 (0.35-1.11)</td><td valign="top" align="left" rowspan="1" colspan="1">.11</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Mental health diagnosis</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Depressive disorder</td><td valign="top" align="left" rowspan="1" colspan="1">100 (69.44)</td><td valign="top" align="left" rowspan="1" colspan="1">184&#x02009;659 (68.59)</td><td valign="top" align="left" rowspan="1" colspan="1">1.04 (0.68-1.60)</td><td valign="top" align="left" rowspan="1" colspan="1">.86</td><td valign="top" align="left" rowspan="1" colspan="1">597 (75.47)</td><td valign="top" align="left" rowspan="1" colspan="1">184&#x02009;162 (68.57)</td><td valign="top" align="left" rowspan="1" colspan="1">1.41 (1.11-1.79)</td><td valign="top" align="left" rowspan="1" colspan="1">.005</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Bipolar disorder</td><td valign="top" align="left" rowspan="1" colspan="1">35 (24.31)</td><td valign="top" align="left" rowspan="1" colspan="1">48&#x02009;936 (18.18)</td><td valign="top" align="left" rowspan="1" colspan="1">1.45 (0.81-2.59)</td><td valign="top" align="left" rowspan="1" colspan="1">.21</td><td valign="top" align="left" rowspan="1" colspan="1">222 (28.07)</td><td valign="top" align="left" rowspan="1" colspan="1">48&#x02009;749 (18.15)</td><td valign="top" align="left" rowspan="1" colspan="1">1.76 (1.28-2.41)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Schizophrenia spectrum disorder</td><td valign="top" align="left" rowspan="1" colspan="1">24 (16.67)</td><td valign="top" align="left" rowspan="1" colspan="1">28&#x02009;729 (10.67)</td><td valign="top" align="left" rowspan="1" colspan="1">1.67 (0.78-3.62)</td><td valign="top" align="left" rowspan="1" colspan="1">.19</td><td valign="top" align="left" rowspan="1" colspan="1">127 (16.06)</td><td valign="top" align="left" rowspan="1" colspan="1">28&#x02009;626 (10.66)</td><td valign="top" align="left" rowspan="1" colspan="1">1.61 (1.06-2.44)</td><td valign="top" align="left" rowspan="1" colspan="1">.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> PTSD</td><td valign="top" align="left" rowspan="1" colspan="1">62 (43.06)</td><td valign="top" align="left" rowspan="1" colspan="1">142&#x02009;700 (53.00)</td><td valign="top" align="left" rowspan="1" colspan="1">0.67 (0.41-1.10)</td><td valign="top" align="left" rowspan="1" colspan="1">.11</td><td valign="top" align="left" rowspan="1" colspan="1">373 (47.16)</td><td valign="top" align="left" rowspan="1" colspan="1">142&#x02009;389 (53.01)</td><td valign="top" align="left" rowspan="1" colspan="1">0.79 (0.61-1.02)</td><td valign="top" align="left" rowspan="1" colspan="1">.07</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Anxiety disorder</td><td valign="top" align="left" rowspan="1" colspan="1">75 (52.08)</td><td valign="top" align="left" rowspan="1" colspan="1">118&#x02009;948 (44.18)</td><td valign="top" align="left" rowspan="1" colspan="1">1.37 (0.86-2.19)</td><td valign="top" align="left" rowspan="1" colspan="1">.18</td><td valign="top" align="left" rowspan="1" colspan="1">469 (59.29)</td><td valign="top" align="left" rowspan="1" colspan="1">118&#x02009;554 (44.14)</td><td valign="top" align="left" rowspan="1" colspan="1">1.84 (1.44-2.36)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> AUD and/or SUD</td><td valign="top" align="left" rowspan="1" colspan="1">82 (56.94)</td><td valign="top" align="left" rowspan="1" colspan="1">149&#x02009;724 (55.61)</td><td valign="top" align="left" rowspan="1" colspan="1">1.06 (0.66-1.68)</td><td valign="top" align="left" rowspan="1" colspan="1">.82</td><td valign="top" align="left" rowspan="1" colspan="1">517 (65.36)</td><td valign="top" align="left" rowspan="1" colspan="1">149&#x02009;289 (55.58)</td><td valign="top" align="left" rowspan="1" colspan="1">1.51 (1.16-1.97)</td><td valign="top" align="left" rowspan="1" colspan="1">.003</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Insomnia disorder</td><td valign="top" align="left" rowspan="1" colspan="1">43 (29.86)</td><td valign="top" align="left" rowspan="1" colspan="1">69&#x02009;925 (25.97)</td><td valign="top" align="left" rowspan="1" colspan="1">1.21 (0.70-2.10)</td><td valign="top" align="left" rowspan="1" colspan="1">.49</td><td valign="top" align="left" rowspan="1" colspan="1">246 (31.10)</td><td valign="top" align="left" rowspan="1" colspan="1">69&#x02009;722 (25.96)</td><td valign="top" align="left" rowspan="1" colspan="1">1.29 (0.97-1.72)</td><td valign="top" align="left" rowspan="1" colspan="1">.08</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: AUD, alcohol use disorder; CSRE, Comprehensive Suicide Risk Evaluation; ED, emergency department; HR, hazard ratio; IP, inpatient; MH, mental health; NA, not applicable; OP, outpatient; PCMHI, primary care&#x02013;mental health integration; PTSD, posttraumatic stress disorder; SUD, substance use disorder.</p><fn id="zoi241712t1n1"><label>
<sup>a</sup>
</label><p>Includes data from 269&#x02009;374 valid CSREs from 153&#x02009;736 patients. Cell sizes of less than 10 patients are suppressed per privacy guidelines. Numbers may not sum to totals in column headings owing to missing data.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="zoi241712t2"><label>Table 2. </label><caption><title>Characteristics of Unique CSRE Administrations<xref rid="zoi241712t2n1" ref-type="table-fn"><sup>a</sup></xref></title></caption><table frame="hsides" rules="groups"><col width="22.17%" span="1"/><col width="10.5%" span="1"/><col width="11.14%" span="1"/><col width="11.68%" span="1"/><col width="5.28%" span="1"/><col width="0.22%" span="1"/><col width="10.28%" span="1"/><col width="10.61%" span="1"/><col width="12.64%" span="1"/><col width="5.26%" span="1"/><col width="0.22%" span="1"/><thead><tr><th rowspan="3" valign="top" align="left" scope="col" colspan="1">Variable</th><th colspan="5" valign="top" align="left" scope="colgroup" rowspan="1">Suicide within 30 d</th><th colspan="5" valign="top" align="left" scope="colgroup" rowspan="1">Suicide within 365 d</th></tr><tr><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">No. (%) of CSREs</th><th rowspan="2" valign="top" align="left" scope="col" colspan="1">HR (95% CI)</th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"><italic>P</italic> value</th><th colspan="3" valign="top" align="left" scope="colgroup" rowspan="1">No. (%) of CSREs</th><th rowspan="2" valign="top" align="left" scope="col" colspan="1">HR (95% CI)</th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"><italic>P</italic> value</th></tr><tr><th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Present (n&#x02009;=&#x02009;144)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Absent (n&#x02009;=&#x02009;269&#x02009;230)</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Present (n&#x02009;=&#x02009;791)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Absent (n&#x02009;=&#x02009;268&#x02009;583)</th></tr></thead><tbody><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">CSRE</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td colspan="2" valign="top" align="left" rowspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Suicidal ideation</td><td valign="top" align="left" rowspan="1" colspan="1">128 (88.89)</td><td valign="top" align="left" rowspan="1" colspan="1">180&#x02009;285 (66.96)</td><td valign="top" align="left" rowspan="1" colspan="1">3.94 (2.19-7.09)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td colspan="2" valign="top" align="left" rowspan="1">672 (84.96)</td><td valign="top" align="left" rowspan="1" colspan="1">179&#x02009;741 (66.92)</td><td valign="top" align="left" rowspan="1" colspan="1">2.78 (2.13-3.63)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Firearm access</td><td valign="top" align="left" rowspan="1" colspan="1">35 (24.31)</td><td valign="top" align="left" rowspan="1" colspan="1">44&#x02009;283 (16.45)</td><td valign="top" align="left" rowspan="1" colspan="1">1.63 (1.04-2.56)</td><td valign="top" align="left" rowspan="1" colspan="1">.03</td><td colspan="2" valign="top" align="left" rowspan="1">149 (18.84)</td><td valign="top" align="left" rowspan="1" colspan="1">44&#x02009;169 (16.44)</td><td valign="top" align="left" rowspan="1" colspan="1">1.17 (0.90-1.53)</td><td valign="top" align="left" rowspan="1" colspan="1">.24</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other lethal means access</td><td valign="top" align="left" rowspan="1" colspan="1">38 (26.39)</td><td valign="top" align="left" rowspan="1" colspan="1">44&#x02009;105 (16.38)</td><td valign="top" align="left" rowspan="1" colspan="1">1.83 (1.19-2.82)</td><td valign="top" align="left" rowspan="1" colspan="1">.006</td><td colspan="2" valign="top" align="left" rowspan="1">179 (22.63)</td><td valign="top" align="left" rowspan="1" colspan="1">43&#x02009;964 (16.37)</td><td valign="top" align="left" rowspan="1" colspan="1">1.49 (1.19-1.87)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Prior suicide attempt</td><td valign="top" align="left" rowspan="1" colspan="1">16 (11.11)</td><td valign="top" align="left" rowspan="1" colspan="1">33&#x02009;488 (12.44)</td><td valign="top" align="left" rowspan="1" colspan="1">0.88 (0.51-1.51)</td><td valign="top" align="left" rowspan="1" colspan="1">.64</td><td colspan="2" valign="top" align="left" rowspan="1">133 (16.81)</td><td valign="top" align="left" rowspan="1" colspan="1">33&#x02009;371 (12.42)</td><td valign="top" align="left" rowspan="1" colspan="1">1.42 (1.16-1.74)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Preparatory behavior</td><td valign="top" align="left" rowspan="1" colspan="1">16 (11.11)</td><td valign="top" align="left" rowspan="1" colspan="1">11&#x02009;703 (4.35)</td><td valign="top" align="left" rowspan="1" colspan="1">2.75 (1.64-4.60)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td colspan="2" valign="top" align="left" rowspan="1">59 (7.46)</td><td valign="top" align="left" rowspan="1" colspan="1">11&#x02009;660 (4.34)</td><td valign="top" align="left" rowspan="1" colspan="1">1.77 (1.34-2.32)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Warning signs</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td colspan="2" valign="top" align="left" rowspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Suicidal communication</td><td valign="top" align="left" rowspan="1" colspan="1">40 (27.78)</td><td valign="top" align="left" rowspan="1" colspan="1">35&#x02009;915 (13.34)</td><td valign="top" align="left" rowspan="1" colspan="1">2.50 (1.75-3.57)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td colspan="2" valign="top" align="left" rowspan="1">182 (23.01)</td><td valign="top" align="left" rowspan="1" colspan="1">35&#x02009;773 (13.32)</td><td valign="top" align="left" rowspan="1" colspan="1">1.95 (1.61-2.36)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Direct preparations</td><td valign="top" align="left" rowspan="1" colspan="1">23 (15.97)</td><td valign="top" align="left" rowspan="1" colspan="1">10&#x02009;905 (4.05)</td><td valign="top" align="left" rowspan="1" colspan="1">4.50 (2.94-6.89)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td colspan="2" valign="top" align="left" rowspan="1">85 (10.75)</td><td valign="top" align="left" rowspan="1" colspan="1">10&#x02009;843 (4.04)</td><td valign="top" align="left" rowspan="1" colspan="1">2.85 (2.12-3.82)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Seeking lethal means access</td><td valign="top" align="left" rowspan="1" colspan="1">21 (14.58)</td><td valign="top" align="left" rowspan="1" colspan="1">10&#x02009;442 (3.88)</td><td valign="top" align="left" rowspan="1" colspan="1">4.23 (2.65-6.75)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td colspan="2" valign="top" align="left" rowspan="1">74 (9.36)</td><td valign="top" align="left" rowspan="1" colspan="1">10&#x02009;389 (3.87)</td><td valign="top" align="left" rowspan="1" colspan="1">2.56 (1.96-3.34)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Anger</td><td valign="top" align="left" rowspan="1" colspan="1">19 (13.19)</td><td valign="top" align="left" rowspan="1" colspan="1">44&#x02009;491 (16.53)</td><td valign="top" align="left" rowspan="1" colspan="1">0.77 (0.46-1.28)</td><td valign="top" align="left" rowspan="1" colspan="1">.31</td><td colspan="2" valign="top" align="left" rowspan="1">112 (14.16)</td><td valign="top" align="left" rowspan="1" colspan="1">44&#x02009;398 (16.53)</td><td valign="top" align="left" rowspan="1" colspan="1">0.83 (0.67-1.04)</td><td valign="top" align="left" rowspan="1" colspan="1">.10</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Anxiety</td><td valign="top" align="left" rowspan="1" colspan="1">61 (42.36)</td><td valign="top" align="left" rowspan="1" colspan="1">77&#x02009;665 (28.85)</td><td valign="top" align="left" rowspan="1" colspan="1">1.81 (1.24-2.65)</td><td valign="top" align="left" rowspan="1" colspan="1">.002</td><td colspan="2" valign="top" align="left" rowspan="1">294 (37.17)</td><td valign="top" align="left" rowspan="1" colspan="1">77&#x02009;432 (28.83)</td><td valign="top" align="left" rowspan="1" colspan="1">1.45 (1.22-1.73)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Guilt</td><td valign="top" align="left" rowspan="1" colspan="1">31 (21.53)</td><td valign="top" align="left" rowspan="1" colspan="1">44&#x02009;050 (16.36)</td><td valign="top" align="left" rowspan="1" colspan="1">1.40 (0.90-2.18)</td><td valign="top" align="left" rowspan="1" colspan="1">.13</td><td colspan="2" valign="top" align="left" rowspan="1">174 (22.00)</td><td valign="top" align="left" rowspan="1" colspan="1">43&#x02009;907 (16.35)</td><td valign="top" align="left" rowspan="1" colspan="1">1.43 (1.18-1.74)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hopelessness</td><td valign="top" align="left" rowspan="1" colspan="1">48 (33.33)</td><td valign="top" align="left" rowspan="1" colspan="1">64&#x02009;277 (23.87)</td><td valign="top" align="left" rowspan="1" colspan="1">1.60 (1.09-2.34)</td><td valign="top" align="left" rowspan="1" colspan="1">.02</td><td colspan="2" valign="top" align="left" rowspan="1">269 (34.01)</td><td valign="top" align="left" rowspan="1" colspan="1">64&#x02009;056 (23.85)</td><td valign="top" align="left" rowspan="1" colspan="1">1.64 (1.38-1.97)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Increased isolation</td><td valign="top" align="left" rowspan="1" colspan="1">29 (20.14)</td><td valign="top" align="left" rowspan="1" colspan="1">46&#x02009;711 (17.35)</td><td valign="top" align="left" rowspan="1" colspan="1">1.20 (0.75-1.93)</td><td valign="top" align="left" rowspan="1" colspan="1">.45</td><td colspan="2" valign="top" align="left" rowspan="1">176 (22.25)</td><td valign="top" align="left" rowspan="1" colspan="1">46&#x02009;564 (17.34)</td><td valign="top" align="left" rowspan="1" colspan="1">1.36 (1.11-1.67)</td><td valign="top" align="left" rowspan="1" colspan="1">.004</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Reckless behaviors</td><td valign="top" align="left" rowspan="1" colspan="1">14 (9.72)</td><td valign="top" align="left" rowspan="1" colspan="1">16&#x02009;711 (6.21)</td><td valign="top" align="left" rowspan="1" colspan="1">1.63 (0.99-2.67)</td><td valign="top" align="left" rowspan="1" colspan="1">.06</td><td colspan="2" valign="top" align="left" rowspan="1">87 (11.00)</td><td valign="top" align="left" rowspan="1" colspan="1">16&#x02009;638 (6.19)</td><td valign="top" align="left" rowspan="1" colspan="1">1.87 (1.41-2.46)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Sleep disturbance</td><td valign="top" align="left" rowspan="1" colspan="1">36 (25.00)</td><td valign="top" align="left" rowspan="1" colspan="1">65&#x02009;061 (24.17)</td><td valign="top" align="left" rowspan="1" colspan="1">1.05 (0.70-1.56)</td><td valign="top" align="left" rowspan="1" colspan="1">.82</td><td colspan="2" valign="top" align="left" rowspan="1">216 (27.31)</td><td valign="top" align="left" rowspan="1" colspan="1">64&#x02009;881 (24.16)</td><td valign="top" align="left" rowspan="1" colspan="1">1.18 (0.99-1.40)</td><td valign="top" align="left" rowspan="1" colspan="1">.07</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Substance abuse</td><td valign="top" align="left" rowspan="1" colspan="1">23 (15.97)</td><td valign="top" align="left" rowspan="1" colspan="1">39&#x02009;018 (14.49)</td><td valign="top" align="left" rowspan="1" colspan="1">1.12 (0.73-1.72)</td><td valign="top" align="left" rowspan="1" colspan="1">.60</td><td colspan="2" valign="top" align="left" rowspan="1">157 (19.85)</td><td valign="top" align="left" rowspan="1" colspan="1">38&#x02009;884 (14.48)</td><td valign="top" align="left" rowspan="1" colspan="1">1.46 (1.18-1.82)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other</td><td valign="top" align="left" rowspan="1" colspan="1">17 (11.81)</td><td valign="top" align="left" rowspan="1" colspan="1">20&#x02009;772 (7.72)</td><td valign="top" align="left" rowspan="1" colspan="1">1.60 (0.95-2.71)</td><td valign="top" align="left" rowspan="1" colspan="1">.08</td><td colspan="2" valign="top" align="left" rowspan="1">94 (11.88)</td><td valign="top" align="left" rowspan="1" colspan="1">20&#x02009;695 (7.71)</td><td valign="top" align="left" rowspan="1" colspan="1">1.62 (1.29-2.03)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Risk factors</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td colspan="2" valign="top" align="left" rowspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> History of suicidal behavior</td><td valign="top" align="left" rowspan="1" colspan="1">69 (47.92)</td><td valign="top" align="left" rowspan="1" colspan="1">105&#x02009;934 (39.35)</td><td valign="top" align="left" rowspan="1" colspan="1">1.42 (0.92-2.18)</td><td valign="top" align="left" rowspan="1" colspan="1">.11</td><td colspan="2" valign="top" align="left" rowspan="1">437 (55.25)</td><td valign="top" align="left" rowspan="1" colspan="1">105&#x02009;566 (39.30)</td><td valign="top" align="left" rowspan="1" colspan="1">1.90 (1.52-2.38)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Recent stressor</td><td valign="top" align="left" rowspan="1" colspan="1">95 (65.97)</td><td valign="top" align="left" rowspan="1" colspan="1">151&#x02009;533 (56.28)</td><td valign="top" align="left" rowspan="1" colspan="1">1.51 (0.98-2.31)</td><td valign="top" align="left" rowspan="1" colspan="1">.06</td><td colspan="2" valign="top" align="left" rowspan="1">499 (63.08)</td><td valign="top" align="left" rowspan="1" colspan="1">151&#x02009;129 (56.27)</td><td valign="top" align="left" rowspan="1" colspan="1">1.32 (1.07-1.63)</td><td valign="top" align="left" rowspan="1" colspan="1">.009</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Access to lethal means</td><td valign="top" align="left" rowspan="1" colspan="1">45 (31.25)</td><td valign="top" align="left" rowspan="1" colspan="1">64&#x02009;474 (23.95)</td><td valign="top" align="left" rowspan="1" colspan="1">1.44 (0.99-2.10)</td><td valign="top" align="left" rowspan="1" colspan="1">.06</td><td colspan="2" valign="top" align="left" rowspan="1">240 (30.34)</td><td valign="top" align="left" rowspan="1" colspan="1">64&#x02009;279 (23.93)</td><td valign="top" align="left" rowspan="1" colspan="1">1.38 (1.13-1.69)</td><td valign="top" align="left" rowspan="1" colspan="1">.002</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> History of psychiatric hospitalization</td><td valign="top" align="left" rowspan="1" colspan="1">90 (62.50)</td><td valign="top" align="left" rowspan="1" colspan="1">124&#x02009;494 (46.24)</td><td valign="top" align="left" rowspan="1" colspan="1">1.94 (1.30-2.88)</td><td valign="top" align="left" rowspan="1" colspan="1">.001</td><td colspan="2" valign="top" align="left" rowspan="1">530 (67.00)</td><td valign="top" align="left" rowspan="1" colspan="1">124&#x02009;054 (46.19)</td><td valign="top" align="left" rowspan="1" colspan="1">2.36 (1.93-2.89)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Psychiatric conditions</td><td valign="top" align="left" rowspan="1" colspan="1">107 (74.31)</td><td valign="top" align="left" rowspan="1" colspan="1">197&#x02009;821 (73.48)</td><td valign="top" align="left" rowspan="1" colspan="1">1.04 (0.69-1.59)</td><td valign="top" align="left" rowspan="1" colspan="1">.85</td><td colspan="2" valign="top" align="left" rowspan="1">624 (78.89)</td><td valign="top" align="left" rowspan="1" colspan="1">197&#x02009;304 (73.46)</td><td valign="top" align="left" rowspan="1" colspan="1">1.34 (1.10-1.64)</td><td valign="top" align="left" rowspan="1" colspan="1">.004</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> History of nonsuicidal self-injury</td><td valign="top" align="left" rowspan="1" colspan="1">11 (7.64)</td><td valign="top" align="left" rowspan="1" colspan="1">17&#x02009;705 (6.58)</td><td valign="top" align="left" rowspan="1" colspan="1">1.17 (0.60-2.30)</td><td valign="top" align="left" rowspan="1" colspan="1">.64</td><td colspan="2" valign="top" align="left" rowspan="1">77 (9.73)</td><td valign="top" align="left" rowspan="1" colspan="1">17&#x02009;639 (6.57)</td><td valign="top" align="left" rowspan="1" colspan="1">1.52 (1.09-2.13)</td><td valign="top" align="left" rowspan="1" colspan="1">.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Recent losses</td><td valign="top" align="left" rowspan="1" colspan="1">32 (22.22)</td><td valign="top" align="left" rowspan="1" colspan="1">55&#x02009;359 (20.56)</td><td valign="top" align="left" rowspan="1" colspan="1">1.10 (0.70-1.74)</td><td valign="top" align="left" rowspan="1" colspan="1">.67</td><td colspan="2" valign="top" align="left" rowspan="1">174 (22.00)</td><td valign="top" align="left" rowspan="1" colspan="1">55&#x02009;217 (20.56)</td><td valign="top" align="left" rowspan="1" colspan="1">1.09 (0.87-1.36)</td><td valign="top" align="left" rowspan="1" colspan="1">.46</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Preexisting risk factors (eg, trauma)</td><td valign="top" align="left" rowspan="1" colspan="1">34 (23.61)</td><td valign="top" align="left" rowspan="1" colspan="1">85&#x02009;249 (31.66)</td><td valign="top" align="left" rowspan="1" colspan="1">0.67 (0.44-1.01)</td><td valign="top" align="left" rowspan="1" colspan="1">.06</td><td colspan="2" valign="top" align="left" rowspan="1">221 (27.94)</td><td valign="top" align="left" rowspan="1" colspan="1">85&#x02009;062 (31.67)</td><td valign="top" align="left" rowspan="1" colspan="1">0.83 (0.68-1.02)</td><td valign="top" align="left" rowspan="1" colspan="1">.08</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Chronic medical condition</td><td valign="top" align="left" rowspan="1" colspan="1">57 (39.58)</td><td valign="top" align="left" rowspan="1" colspan="1">98&#x02009;559 (36.61)</td><td valign="top" align="left" rowspan="1" colspan="1">1.14 (0.73-1.76)</td><td valign="top" align="left" rowspan="1" colspan="1">.57</td><td colspan="2" valign="top" align="left" rowspan="1">310 (39.19)</td><td valign="top" align="left" rowspan="1" colspan="1">98&#x02009;306 (36.60)</td><td valign="top" align="left" rowspan="1" colspan="1">1.13 (0.93-1.37)</td><td valign="top" align="left" rowspan="1" colspan="1">.23</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Marginalized group status</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td colspan="2" valign="top" align="left" rowspan="1">32 (4.05)</td><td valign="top" align="left" rowspan="1" colspan="1">11&#x02009;239 (4.18)</td><td valign="top" align="left" rowspan="1" colspan="1">0.96 (0.52-1.77)</td><td valign="top" align="left" rowspan="1" colspan="1">.91</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Recent transition from military</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td colspan="2" valign="top" align="left" rowspan="1">12 (1.52)</td><td valign="top" align="left" rowspan="1" colspan="1">8603 (3.20)</td><td valign="top" align="left" rowspan="1" colspan="1">0.46 (0.26-0.82)</td><td valign="top" align="left" rowspan="1" colspan="1">.008</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td colspan="2" valign="top" align="left" rowspan="1">57 (7.21)</td><td valign="top" align="left" rowspan="1" colspan="1">15&#x02009;060 (5.61)</td><td valign="top" align="left" rowspan="1" colspan="1">1.31 (0.90-1.91)</td><td valign="top" align="left" rowspan="1" colspan="1">.16</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Protective factor</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td colspan="2" valign="top" align="left" rowspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Access to health care</td><td valign="top" align="left" rowspan="1" colspan="1">92 (63.89)</td><td valign="top" align="left" rowspan="1" colspan="1">179&#x02009;710 (66.75)</td><td valign="top" align="left" rowspan="1" colspan="1">0.88 (0.60-1.30)</td><td valign="top" align="left" rowspan="1" colspan="1">.53</td><td colspan="2" valign="top" align="left" rowspan="1">535 (67.64)</td><td valign="top" align="left" rowspan="1" colspan="1">179&#x02009;267 (66.75)</td><td valign="top" align="left" rowspan="1" colspan="1">1.04 (0.87-1.25)</td><td valign="top" align="left" rowspan="1" colspan="1">.65</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Motivation for medical treatment</td><td valign="top" align="left" rowspan="1" colspan="1">64 (44.44)</td><td valign="top" align="left" rowspan="1" colspan="1">134&#x02009;690 (50.03)</td><td valign="top" align="left" rowspan="1" colspan="1">0.80 (0.56-1.14)</td><td valign="top" align="left" rowspan="1" colspan="1">.22</td><td colspan="2" valign="top" align="left" rowspan="1">406 (51.33)</td><td valign="top" align="left" rowspan="1" colspan="1">134&#x02009;348 (50.02)</td><td valign="top" align="left" rowspan="1" colspan="1">1.06 (0.89-1.26)</td><td valign="top" align="left" rowspan="1" colspan="1">.54</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Access to MH care</td><td valign="top" align="left" rowspan="1" colspan="1">93 (64.58)</td><td valign="top" align="left" rowspan="1" colspan="1">177&#x02009;848 (66.06)</td><td valign="top" align="left" rowspan="1" colspan="1">0.94 (0.62-1.41)</td><td valign="top" align="left" rowspan="1" colspan="1">.75</td><td colspan="2" valign="top" align="left" rowspan="1">541 (68.39)</td><td valign="top" align="left" rowspan="1" colspan="1">177&#x02009;400 (66.05)</td><td valign="top" align="left" rowspan="1" colspan="1">1.11 (0.92-1.33)</td><td valign="top" align="left" rowspan="1" colspan="1">.28</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Motivation for MH treatment</td><td valign="top" align="left" rowspan="1" colspan="1">88 (61.11)</td><td valign="top" align="left" rowspan="1" colspan="1">181&#x02009;066 (67.25)</td><td valign="top" align="left" rowspan="1" colspan="1">0.76 (0.54-1.07)</td><td valign="top" align="left" rowspan="1" colspan="1">.12</td><td colspan="2" valign="top" align="left" rowspan="1">551 (69.66)</td><td valign="top" align="left" rowspan="1" colspan="1">180&#x02009;603 (67.24)</td><td valign="top" align="left" rowspan="1" colspan="1">1.11 (0.91-1.35)</td><td valign="top" align="left" rowspan="1" colspan="1">.30</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Positive interpersonal relationships</td><td valign="top" align="left" rowspan="1" colspan="1">93 (64.58)</td><td valign="top" align="left" rowspan="1" colspan="1">165&#x02009;322 (61.41)</td><td valign="top" align="left" rowspan="1" colspan="1">1.15 (0.78-1.68)</td><td valign="top" align="left" rowspan="1" colspan="1">.48</td><td colspan="2" valign="top" align="left" rowspan="1">473 (59.80)</td><td valign="top" align="left" rowspan="1" colspan="1">164&#x02009;942 (61.41)</td><td valign="top" align="left" rowspan="1" colspan="1">0.93 (0.77-1.13)</td><td valign="top" align="left" rowspan="1" colspan="1">.47</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Significant other</td><td valign="top" align="left" rowspan="1" colspan="1">41 (28.47)</td><td valign="top" align="left" rowspan="1" colspan="1">90&#x02009;674 (33.68)</td><td valign="top" align="left" rowspan="1" colspan="1">0.78 (0.48-1.27)</td><td valign="top" align="left" rowspan="1" colspan="1">.32</td><td colspan="2" valign="top" align="left" rowspan="1">254 (32.11)</td><td valign="top" align="left" rowspan="1" colspan="1">90&#x02009;461 (33.68)</td><td valign="top" align="left" rowspan="1" colspan="1">0.93 (0.72-1.19)</td><td valign="top" align="left" rowspan="1" colspan="1">.55</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Caregiving responsibilities</td><td valign="top" align="left" rowspan="1" colspan="1">35 (24.31)</td><td valign="top" align="left" rowspan="1" colspan="1">70&#x02009;774 (26.29)</td><td valign="top" align="left" rowspan="1" colspan="1">0.90 (0.54-1.51)</td><td valign="top" align="left" rowspan="1" colspan="1">.69</td><td colspan="2" valign="top" align="left" rowspan="1">175 (22.12)</td><td valign="top" align="left" rowspan="1" colspan="1">70&#x02009;634 (26.30)</td><td valign="top" align="left" rowspan="1" colspan="1">0.79 (0.61-1.03)</td><td valign="top" align="left" rowspan="1" colspan="1">.08</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hope for the future</td><td valign="top" align="left" rowspan="1" colspan="1">72 (50.00)</td><td valign="top" align="left" rowspan="1" colspan="1">141&#x02009;487 (52.55)</td><td valign="top" align="left" rowspan="1" colspan="1">0.90 (0.62-1.31)</td><td valign="top" align="left" rowspan="1" colspan="1">.59</td><td colspan="2" valign="top" align="left" rowspan="1">398 (50.32)</td><td valign="top" align="left" rowspan="1" colspan="1">141&#x02009;161 (52.56)</td><td valign="top" align="left" rowspan="1" colspan="1">0.91 (0.77-1.08)</td><td valign="top" align="left" rowspan="1" colspan="1">.28</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Personal traits or beliefs against suicide</td><td valign="top" align="left" rowspan="1" colspan="1">55 (38.19)</td><td valign="top" align="left" rowspan="1" colspan="1">109&#x02009;678 (40.74)</td><td valign="top" align="left" rowspan="1" colspan="1">0.90 (0.62-1.30)</td><td valign="top" align="left" rowspan="1" colspan="1">.57</td><td colspan="2" valign="top" align="left" rowspan="1">277 (35.02)</td><td valign="top" align="left" rowspan="1" colspan="1">109&#x02009;456 (40.75)</td><td valign="top" align="left" rowspan="1" colspan="1">0.78 (0.65-0.94)<xref rid="zoi241712t2n2" ref-type="table-fn"><sup>b</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Religious beliefs against suicide</td><td valign="top" align="left" rowspan="1" colspan="1">31 (21.53)</td><td valign="top" align="left" rowspan="1" colspan="1">73&#x02009;896 (27.45)</td><td valign="top" align="left" rowspan="1" colspan="1">0.73 (0.43-1.23)</td><td valign="top" align="left" rowspan="1" colspan="1">.23</td><td colspan="2" valign="top" align="left" rowspan="1">173 (21.87)</td><td valign="top" align="left" rowspan="1" colspan="1">73&#x02009;754 (27.46)</td><td valign="top" align="left" rowspan="1" colspan="1">0.74 (0.57-0.96)</td><td valign="top" align="left" rowspan="1" colspan="1">.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Cultural connections</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td colspan="2" valign="top" align="left" rowspan="1">43 (5.44)</td><td valign="top" align="left" rowspan="1" colspan="1">22&#x02009;606 (8.42)</td><td valign="top" align="left" rowspan="1" colspan="1">0.63 (0.44-0.90)</td><td valign="top" align="left" rowspan="1" colspan="1">.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Social support</td><td valign="top" align="left" rowspan="1" colspan="1">39 (27.08)</td><td valign="top" align="left" rowspan="1" colspan="1">80&#x02009;821 (30.02)</td><td valign="top" align="left" rowspan="1" colspan="1">0.87 (0.60-1.26)</td><td valign="top" align="left" rowspan="1" colspan="1">.45</td><td colspan="2" valign="top" align="left" rowspan="1">214 (27.05)</td><td valign="top" align="left" rowspan="1" colspan="1">80&#x02009;646 (30.03)</td><td valign="top" align="left" rowspan="1" colspan="1">0.86 (0.71-1.05)</td><td valign="top" align="left" rowspan="1" colspan="1">.14</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Desire to live</td><td valign="top" align="left" rowspan="1" colspan="1">51 (35.42)</td><td valign="top" align="left" rowspan="1" colspan="1">107&#x02009;080 (39.77)</td><td valign="top" align="left" rowspan="1" colspan="1">0.83 (0.53-1.29)</td><td valign="top" align="left" rowspan="1" colspan="1">.41</td><td colspan="2" valign="top" align="left" rowspan="1">270 (34.13)</td><td valign="top" align="left" rowspan="1" colspan="1">106&#x02009;861 (39.79)</td><td valign="top" align="left" rowspan="1" colspan="1">0.78 (0.64-0.95)<xref rid="zoi241712t2n2" ref-type="table-fn"><sup>b</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;10</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td colspan="2" valign="top" align="left" rowspan="1">49 (6.19)</td><td valign="top" align="left" rowspan="1" colspan="1">11&#x02009;801 (4.39)</td><td valign="top" align="left" rowspan="1" colspan="1">1.44 (0.98-2.11)</td><td valign="top" align="left" rowspan="1" colspan="1">.06</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Acute suicide risk</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td colspan="2" valign="top" align="left" rowspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Low</td><td valign="top" align="left" rowspan="1" colspan="1">73 (50.69)</td><td valign="top" align="left" rowspan="1" colspan="1">186&#x02009;670 (69.38)</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td colspan="2" valign="top" align="left" rowspan="1">399 (50.44)</td><td valign="top" align="left" rowspan="1" colspan="1">186&#x02009;344 (69.42)</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Intermediate</td><td valign="top" align="left" rowspan="1" colspan="1">47 (32.64)</td><td valign="top" align="left" rowspan="1" colspan="1">63&#x02009;235 (23.50)</td><td valign="top" align="left" rowspan="1" colspan="1">1.90 (1.28-2.83)</td><td valign="top" align="left" rowspan="1" colspan="1">.002</td><td colspan="2" valign="top" align="left" rowspan="1">281 (35.52)</td><td valign="top" align="left" rowspan="1" colspan="1">63&#x02009;001 (23.47)</td><td valign="top" align="left" rowspan="1" colspan="1">2.08 (1.73-2.49)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> High</td><td valign="top" align="left" rowspan="1" colspan="1">24 (16.67)</td><td valign="top" align="left" rowspan="1" colspan="1">19&#x02009;159 (7.12)</td><td valign="top" align="left" rowspan="1" colspan="1">3.21 (1.99-5.17)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td colspan="2" valign="top" align="left" rowspan="1">111 (14.03)</td><td valign="top" align="left" rowspan="1" colspan="1">19&#x02009;072 (7.11)</td><td valign="top" align="left" rowspan="1" colspan="1">2.72 (2.14-3.46)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chronic suicide risk</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td colspan="2" valign="top" align="left" rowspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Low</td><td valign="top" align="left" rowspan="1" colspan="1">39 (27.08)</td><td valign="top" align="left" rowspan="1" colspan="1">126&#x02009;711 (47.09)</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td colspan="2" valign="top" align="left" rowspan="1">203 (25.66)</td><td valign="top" align="left" rowspan="1" colspan="1">126&#x02009;547 (47.15)</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Intermediate</td><td valign="top" align="left" rowspan="1" colspan="1">75 (52.08)</td><td valign="top" align="left" rowspan="1" colspan="1">116&#x02009;810 (43.41)</td><td valign="top" align="left" rowspan="1" colspan="1">2.09 (1.33-3.27)</td><td valign="top" align="left" rowspan="1" colspan="1">.001</td><td colspan="2" valign="top" align="left" rowspan="1">429 (54.24)</td><td valign="top" align="left" rowspan="1" colspan="1">116&#x02009;456 (43.39)</td><td valign="top" align="left" rowspan="1" colspan="1">2.29 (1.82-2.89)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> High</td><td valign="top" align="left" rowspan="1" colspan="1">30 (20.83)</td><td valign="top" align="left" rowspan="1" colspan="1">25&#x02009;539 (9.49)</td><td valign="top" align="left" rowspan="1" colspan="1">3.82 (2.16-6.73)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td colspan="2" valign="top" align="left" rowspan="1">159 (20.10)</td><td valign="top" align="left" rowspan="1" colspan="1">25&#x02009;410 (9.47)</td><td valign="top" align="left" rowspan="1" colspan="1">3.89 (2.92-5.19)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: CSRE, Comprehensive Suicide Risk Evaluation; HR, hazard ratio; MH, mental health; MHC, mental health clinic; NA, not applicable.</p><fn id="zoi241712t2n1"><label>
<sup>a</sup>
</label><p>Includes data from 269 374 valid CSREs from 153 736 patients. Cell sizes less than 10 patients are suppressed per privacy guidelines. Numbers may not sum to totals in column headings owing to missing data. Numbers may not sum to totals in column headings owing to missing data.</p></fn><fn id="zoi241712t2n2"><label>
<sup>b</sup>
</label><p>Effect did not meet criteria for being statistically and clinically significant (ie, HR &#x02264;0.77 or &#x02265;1.30 [<italic>P</italic>&#x02009;&#x02264;&#x02009;.05]).</p></fn></table-wrap-foot></table-wrap><sec id="H2-5-ZOI241712"><title>Suicide in the 30 Days After CSRE Administration</title><p>Of the 791 suicides in the 365 days following a CSRE, 144 occurred within 30 days (18.20%). No variables evidenced problematic multicollinearity based on bivariate correlations, variance inflation factors, or tolerance values, and the proportional hazards assumption held for patients with and without suicidal ideation on the CSRE. Increased suicide risk within 30 days of CSRE administration was found for CSREs with suicidal ideation (HR,&#x02009;3.14; 95% CI, 1.51-6.54) (<xref rid="zoi241712t3" ref-type="table">Table 3</xref>), firearm access (HR,&#x02009;2.62; 95% CI, 1.49-4.61), direct preparations for a suicide attempt (HR,&#x02009;2.15; 95% CI, 1.27-3.62), seeking access to lethal means (HR,&#x02009;2.04; 95% CI, 1.11-3.75), anxiety (HR,&#x02009;1.80; 95% CI, 1.16-2.81), and history of psychiatric hospitalization (HR,&#x02009;1.63; 95% CI, 1.02-2.61). Anger (HR,&#x02009;0.50; 95% CI, 0.30-0.85) was associated with decreased suicide risk within 30 days of CSRE administration.</p><table-wrap position="float" id="zoi241712t3"><label>Table 3. </label><caption><title>Cox Proportional Hazards Regression Models Examining Associations With Suicide Within 30 and 365 Days of CSRE Administration</title></caption><table frame="hsides" rules="groups"><col width="37.74%" span="1"/><col width="20.2%" span="1"/><col width="10.42%" span="1"/><col width="20.67%" span="1"/><col width="10.97%" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Predictive factor</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Suicide within 30 d (n&#x02009;=&#x02009;269 196)</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Suicide within 365 d (n&#x02009;=&#x02009;269 196)</th></tr><tr><th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">HR (95% CI)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic>P</italic> value</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">HR (95% CI)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Age, y</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 18-34</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference] </td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference] </td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 35-54</td><td valign="top" align="left" rowspan="1" colspan="1">1.33 (0.62-2.86)</td><td valign="top" align="left" rowspan="1" colspan="1">.47</td><td valign="top" align="left" rowspan="1" colspan="1">0.73 (0.52-1.02)</td><td valign="top" align="left" rowspan="1" colspan="1">.07</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &#x02265;55</td><td valign="top" align="left" rowspan="1" colspan="1">1.18 (0.56-2.46)</td><td valign="top" align="left" rowspan="1" colspan="1">.67</td><td valign="top" align="left" rowspan="1" colspan="1">0.60 (0.40-0.91)</td><td valign="top" align="left" rowspan="1" colspan="1">.02</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Sex</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Female </td><td valign="top" align="left" rowspan="1" colspan="1">1.17 (0.51-2.70)</td><td valign="top" align="left" rowspan="1" colspan="1">.71</td><td valign="top" align="left" rowspan="1" colspan="1">0.71 (0.45-1.11)</td><td valign="top" align="left" rowspan="1" colspan="1">.13</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Male</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference] </td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference] </td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Race</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> American Indian or Alaska Native</td><td valign="top" align="left" rowspan="1" colspan="1">0.62 (0.08-4.61)</td><td valign="top" align="left" rowspan="1" colspan="1">.64</td><td valign="top" align="left" rowspan="1" colspan="1">1.11 (0.40-3.11)</td><td valign="top" align="left" rowspan="1" colspan="1">.84</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Asian</td><td valign="top" align="left" rowspan="1" colspan="1">4.22 (0.65-27.24)</td><td valign="top" align="left" rowspan="1" colspan="1">.13</td><td valign="top" align="left" rowspan="1" colspan="1">1.45 (0.35-5.95)</td><td valign="top" align="left" rowspan="1" colspan="1">.61</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Black</td><td valign="top" align="left" rowspan="1" colspan="1">0.28 (0.12-0.62)</td><td valign="top" align="left" rowspan="1" colspan="1">.002</td><td valign="top" align="left" rowspan="1" colspan="1">0.23 (0.15-0.36)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Native Hawaiian or Other Pacific Islander</td><td valign="top" align="left" rowspan="1" colspan="1">NA<xref rid="zoi241712t3n2" ref-type="table-fn"><sup>b</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.50 (0.11-2.37)</td><td valign="top" align="left" rowspan="1" colspan="1">.38</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> White</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference] </td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference] </td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Multiracial</td><td valign="top" align="left" rowspan="1" colspan="1">NA<xref rid="zoi241712t3n2" ref-type="table-fn"><sup>b</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.75 (0.15-3.72)</td><td valign="top" align="left" rowspan="1" colspan="1">.72</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Unknown</td><td valign="top" align="left" rowspan="1" colspan="1">1.54 (0.73-3.24)</td><td valign="top" align="left" rowspan="1" colspan="1">.26</td><td valign="top" align="left" rowspan="1" colspan="1">0.75 (0.48-1.17)</td><td valign="top" align="left" rowspan="1" colspan="1">.21</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hispanic ethnicity</td><td valign="top" align="left" rowspan="1" colspan="1">0.24 (0.08-0.79)</td><td valign="top" align="left" rowspan="1" colspan="1">.02</td><td valign="top" align="left" rowspan="1" colspan="1">0.74 (0.45-1.22)</td><td valign="top" align="left" rowspan="1" colspan="1">.23</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Service connection</td><td valign="top" align="left" rowspan="1" colspan="1">0.32 (0.19-0.54)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">0.48 (0.35-0.67)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Setting</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> ED</td><td valign="top" align="left" rowspan="1" colspan="1">1.40 (0.68-2.88)</td><td valign="top" align="left" rowspan="1" colspan="1">.36</td><td valign="top" align="left" rowspan="1" colspan="1">1.09 (0.78-1.52)</td><td valign="top" align="left" rowspan="1" colspan="1">.62</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> IP MH</td><td valign="top" align="left" rowspan="1" colspan="1">1.88 (0.44-8.13)</td><td valign="top" align="left" rowspan="1" colspan="1">.40</td><td valign="top" align="left" rowspan="1" colspan="1">1.53 (0.73-3.19)</td><td valign="top" align="left" rowspan="1" colspan="1">.26</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> IP non-MH</td><td valign="top" align="left" rowspan="1" colspan="1">NA<xref rid="zoi241712t3n2" ref-type="table-fn"><sup>b</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1.97 (0.49-7.99)</td><td valign="top" align="left" rowspan="1" colspan="1">.34</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> OP non-MH</td><td valign="top" align="left" rowspan="1" colspan="1">1.10 (0.72-1.70)</td><td valign="top" align="left" rowspan="1" colspan="1">.66</td><td valign="top" align="left" rowspan="1" colspan="1">1.08 (0.85-1.37)</td><td valign="top" align="left" rowspan="1" colspan="1">.54</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Primary care</td><td valign="top" align="left" rowspan="1" colspan="1">0.84 (0.11-6.32)</td><td valign="top" align="left" rowspan="1" colspan="1">.87</td><td valign="top" align="left" rowspan="1" colspan="1">1.00 (0.41-2.44)</td><td valign="top" align="left" rowspan="1" colspan="1">.99</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> PCMHI</td><td valign="top" align="left" rowspan="1" colspan="1">0.23 (0.03-1.72)</td><td valign="top" align="left" rowspan="1" colspan="1">.15</td><td valign="top" align="left" rowspan="1" colspan="1">0.65 (0.36-1.16)</td><td valign="top" align="left" rowspan="1" colspan="1">.14</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> MHC</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference] </td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference] </td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Depressive disorder</td><td valign="top" align="left" rowspan="1" colspan="1">0.81 (0.50-1.31)</td><td valign="top" align="left" rowspan="1" colspan="1">.39</td><td valign="top" align="left" rowspan="1" colspan="1">1.03 (0.80-1.33)</td><td valign="top" align="left" rowspan="1" colspan="1">.83</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bipolar disorder</td><td valign="top" align="left" rowspan="1" colspan="1">1.07 (0.61-1.89)</td><td valign="top" align="left" rowspan="1" colspan="1">.81</td><td valign="top" align="left" rowspan="1" colspan="1">1.22 (0.89-1.69)</td><td valign="top" align="left" rowspan="1" colspan="1">.22</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Schizophrenia spectrum disorder</td><td valign="top" align="left" rowspan="1" colspan="1">1.51 (0.67-3.42)</td><td valign="top" align="left" rowspan="1" colspan="1">.32</td><td valign="top" align="left" rowspan="1" colspan="1">1.37 (0.86-2.19)</td><td valign="top" align="left" rowspan="1" colspan="1">.18</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PTSD</td><td valign="top" align="left" rowspan="1" colspan="1">0.86 (0.56-1.31)</td><td valign="top" align="left" rowspan="1" colspan="1">.47</td><td valign="top" align="left" rowspan="1" colspan="1">0.75 (0.58-0.98)</td><td valign="top" align="left" rowspan="1" colspan="1">.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Anxiety disorder</td><td valign="top" align="left" rowspan="1" colspan="1">1.21 (0.74-1.97)</td><td valign="top" align="left" rowspan="1" colspan="1">.46</td><td valign="top" align="left" rowspan="1" colspan="1">1.45 (1.12-1.89)</td><td valign="top" align="left" rowspan="1" colspan="1">.005</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">AUD and/or SUD</td><td valign="top" align="left" rowspan="1" colspan="1">0.93 (0.55-1.57)</td><td valign="top" align="left" rowspan="1" colspan="1">.78</td><td valign="top" align="left" rowspan="1" colspan="1">1.14 (0.84-1.55)</td><td valign="top" align="left" rowspan="1" colspan="1">.40</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Insomnia disorder</td><td valign="top" align="left" rowspan="1" colspan="1">1.09 (0.61-1.95)</td><td valign="top" align="left" rowspan="1" colspan="1">.77</td><td valign="top" align="left" rowspan="1" colspan="1">1.01 (0.76-1.35)</td><td valign="top" align="left" rowspan="1" colspan="1">.95</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">CSRE</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Suicidal ideation</td><td valign="top" align="left" rowspan="1" colspan="1">3.14 (1.51-6.54)</td><td valign="top" align="left" rowspan="1" colspan="1">.002</td><td valign="top" align="left" rowspan="1" colspan="1">1.63 (1.20-2.21)</td><td valign="top" align="left" rowspan="1" colspan="1">.002</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Firearm access</td><td valign="top" align="left" rowspan="1" colspan="1">2.62 (1.49-4.61)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">1.55 (1.13-2.13)</td><td valign="top" align="left" rowspan="1" colspan="1">.006</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other lethal means access</td><td valign="top" align="left" rowspan="1" colspan="1">1.37 (0.88-2.13)</td><td valign="top" align="left" rowspan="1" colspan="1">.16</td><td valign="top" align="left" rowspan="1" colspan="1">0.98 (0.78-1.22)</td><td valign="top" align="left" rowspan="1" colspan="1">.84</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Prior suicide attempt</td><td valign="top" align="left" rowspan="1" colspan="1">0.59 (0.33-1.04)</td><td valign="top" align="left" rowspan="1" colspan="1">.07</td><td valign="top" align="left" rowspan="1" colspan="1">1.00 (0.80-1.26)</td><td valign="top" align="left" rowspan="1" colspan="1">.98</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Preparatory behavior</td><td valign="top" align="left" rowspan="1" colspan="1">1.56 (0.89-2.74)</td><td valign="top" align="left" rowspan="1" colspan="1">.12</td><td valign="top" align="left" rowspan="1" colspan="1">1.11 (0.83-1.49)</td><td valign="top" align="left" rowspan="1" colspan="1">.47</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Warning signs</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Suicidal communication</td><td valign="top" align="left" rowspan="1" colspan="1">1.28 (0.82-2.00)</td><td valign="top" align="left" rowspan="1" colspan="1">.28</td><td valign="top" align="left" rowspan="1" colspan="1">1.13 (0.90-1.42)</td><td valign="top" align="left" rowspan="1" colspan="1">.30</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Direct preparations</td><td valign="top" align="left" rowspan="1" colspan="1">2.15 (1.27-3.62)</td><td valign="top" align="left" rowspan="1" colspan="1">.004</td><td valign="top" align="left" rowspan="1" colspan="1">1.56 (1.09-2.23)</td><td valign="top" align="left" rowspan="1" colspan="1">.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Seeking lethal means access</td><td valign="top" align="left" rowspan="1" colspan="1">2.04 (1.11-3.75)</td><td valign="top" align="left" rowspan="1" colspan="1">.02</td><td valign="top" align="left" rowspan="1" colspan="1">1.23 (0.88-1.72)</td><td valign="top" align="left" rowspan="1" colspan="1">.23</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Anger</td><td valign="top" align="left" rowspan="1" colspan="1">0.50 (0.30-0.85)</td><td valign="top" align="left" rowspan="1" colspan="1">.01</td><td valign="top" align="left" rowspan="1" colspan="1">0.56 (0.44-0.71)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Anxiety</td><td valign="top" align="left" rowspan="1" colspan="1">1.80 (1.16-2.81)</td><td valign="top" align="left" rowspan="1" colspan="1">.009</td><td valign="top" align="left" rowspan="1" colspan="1">1.14 (0.92-1.41)</td><td valign="top" align="left" rowspan="1" colspan="1">.23</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Guilt</td><td valign="top" align="left" rowspan="1" colspan="1">1.11 (0.68-1.82)</td><td valign="top" align="left" rowspan="1" colspan="1">.68</td><td valign="top" align="left" rowspan="1" colspan="1">1.12 (0.90-1.38)</td><td valign="top" align="left" rowspan="1" colspan="1">.32</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hopelessness</td><td valign="top" align="left" rowspan="1" colspan="1">0.86 (0.52-1.41)</td><td valign="top" align="left" rowspan="1" colspan="1">.54</td><td valign="top" align="left" rowspan="1" colspan="1">1.04 (0.84-1.29)</td><td valign="top" align="left" rowspan="1" colspan="1">.72</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Increased isolation</td><td valign="top" align="left" rowspan="1" colspan="1">0.83 (0.48-1.42)</td><td valign="top" align="left" rowspan="1" colspan="1">.49</td><td valign="top" align="left" rowspan="1" colspan="1">0.98 (0.78-1.23)</td><td valign="top" align="left" rowspan="1" colspan="1">.85</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Reckless behaviors</td><td valign="top" align="left" rowspan="1" colspan="1">1.32 (0.77-2.26)</td><td valign="top" align="left" rowspan="1" colspan="1">.31</td><td valign="top" align="left" rowspan="1" colspan="1">1.40 (1.00-1.95)</td><td valign="top" align="left" rowspan="1" colspan="1">.05</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Sleep disturbance</td><td valign="top" align="left" rowspan="1" colspan="1">0.70 (0.42-1.17)</td><td valign="top" align="left" rowspan="1" colspan="1">.17</td><td valign="top" align="left" rowspan="1" colspan="1">0.87 (0.70-1.07)</td><td valign="top" align="left" rowspan="1" colspan="1">.18</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Substance abuse</td><td valign="top" align="left" rowspan="1" colspan="1">0.70 (0.42-1.16)</td><td valign="top" align="left" rowspan="1" colspan="1">.17</td><td valign="top" align="left" rowspan="1" colspan="1">0.94 (0.73-1.21)</td><td valign="top" align="left" rowspan="1" colspan="1">.63</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other</td><td valign="top" align="left" rowspan="1" colspan="1">1.12 (0.66-1.91)</td><td valign="top" align="left" rowspan="1" colspan="1">.66</td><td valign="top" align="left" rowspan="1" colspan="1">1.23 (0.98-1.54)</td><td valign="top" align="left" rowspan="1" colspan="1">.07</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Risk factors</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> History of suicidal behavior</td><td valign="top" align="left" rowspan="1" colspan="1">0.90 (0.56-1.47)</td><td valign="top" align="left" rowspan="1" colspan="1">.68</td><td valign="top" align="left" rowspan="1" colspan="1">1.05 (0.80-1.38)</td><td valign="top" align="left" rowspan="1" colspan="1">.71</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Recent stressor</td><td valign="top" align="left" rowspan="1" colspan="1">1.15 (0.75-1.76)</td><td valign="top" align="left" rowspan="1" colspan="1">.52</td><td valign="top" align="left" rowspan="1" colspan="1">0.96 (0.76-1.20)</td><td valign="top" align="left" rowspan="1" colspan="1">.71</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Access to lethal means</td><td valign="top" align="left" rowspan="1" colspan="1">0.64 (0.39-1.05)</td><td valign="top" align="left" rowspan="1" colspan="1">.08</td><td valign="top" align="left" rowspan="1" colspan="1">0.93 (0.72-1.20)</td><td valign="top" align="left" rowspan="1" colspan="1">.57</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> History of psychiatric hospitalization</td><td valign="top" align="left" rowspan="1" colspan="1">1.63 (1.02-2.61)</td><td valign="top" align="left" rowspan="1" colspan="1">.04</td><td valign="top" align="left" rowspan="1" colspan="1">1.68 (1.32-2.13)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Psychiatric conditions</td><td valign="top" align="left" rowspan="1" colspan="1">0.82 (0.52-1.28)</td><td valign="top" align="left" rowspan="1" colspan="1">.38</td><td valign="top" align="left" rowspan="1" colspan="1">0.99 (0.80-1.22)</td><td valign="top" align="left" rowspan="1" colspan="1">.93</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> History of nonsuicidal self-injury</td><td valign="top" align="left" rowspan="1" colspan="1">0.94 (0.51-1.73)</td><td valign="top" align="left" rowspan="1" colspan="1">.84</td><td valign="top" align="left" rowspan="1" colspan="1">1.03 (0.74-1.44)</td><td valign="top" align="left" rowspan="1" colspan="1">.86</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Recent losses</td><td valign="top" align="left" rowspan="1" colspan="1">0.97 (0.62-1.53)</td><td valign="top" align="left" rowspan="1" colspan="1">.91</td><td valign="top" align="left" rowspan="1" colspan="1">0.97 (0.77-1.22)</td><td valign="top" align="left" rowspan="1" colspan="1">.79</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Preexisting risk factors (eg, trauma)</td><td valign="top" align="left" rowspan="1" colspan="1">0.66 (0.41-1.04)</td><td valign="top" align="left" rowspan="1" colspan="1">.07</td><td valign="top" align="left" rowspan="1" colspan="1">0.77 (0.62-0.96)</td><td valign="top" align="left" rowspan="1" colspan="1">.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Chronic medical condition</td><td valign="top" align="left" rowspan="1" colspan="1">1.19 (0.75-1.90)</td><td valign="top" align="left" rowspan="1" colspan="1">.47</td><td valign="top" align="left" rowspan="1" colspan="1">1.17 (0.94-1.46)</td><td valign="top" align="left" rowspan="1" colspan="1">.16</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Marginalized group status</td><td valign="top" align="left" rowspan="1" colspan="1">0.34 (0.08-1.44)</td><td valign="top" align="left" rowspan="1" colspan="1">.14</td><td valign="top" align="left" rowspan="1" colspan="1">1.02 (0.54-1.93)</td><td valign="top" align="left" rowspan="1" colspan="1">.96</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Recent transition from military</td><td valign="top" align="left" rowspan="1" colspan="1">0.47 (0.11-2.04)</td><td valign="top" align="left" rowspan="1" colspan="1">.31</td><td valign="top" align="left" rowspan="1" colspan="1">0.39 (0.22-0.70)</td><td valign="top" align="left" rowspan="1" colspan="1">.002</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other</td><td valign="top" align="left" rowspan="1" colspan="1">0.89 (0.40-1.97)</td><td valign="top" align="left" rowspan="1" colspan="1">.77</td><td valign="top" align="left" rowspan="1" colspan="1">1.23 (0.86-1.75)</td><td valign="top" align="left" rowspan="1" colspan="1">.26</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Protective factors</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Access to health care</td><td valign="top" align="left" rowspan="1" colspan="1">0.96 (0.59-1.57)</td><td valign="top" align="left" rowspan="1" colspan="1">.88</td><td valign="top" align="left" rowspan="1" colspan="1">1.06 (0.87-1.29)</td><td valign="top" align="left" rowspan="1" colspan="1">.56</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Motivation for medical treatment</td><td valign="top" align="left" rowspan="1" colspan="1">0.85 (0.55-1.31)</td><td valign="top" align="left" rowspan="1" colspan="1">.47</td><td valign="top" align="left" rowspan="1" colspan="1">1.09 (0.91-1.30)</td><td valign="top" align="left" rowspan="1" colspan="1">.35</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Access to MH care</td><td valign="top" align="left" rowspan="1" colspan="1">0.96 (0.62-1.49)</td><td valign="top" align="left" rowspan="1" colspan="1">.86</td><td valign="top" align="left" rowspan="1" colspan="1">0.97 (0.80-1.17)</td><td valign="top" align="left" rowspan="1" colspan="1">.75</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Motivation for MH treatment</td><td valign="top" align="left" rowspan="1" colspan="1">0.73 (0.51-1.05)</td><td valign="top" align="left" rowspan="1" colspan="1">.09</td><td valign="top" align="left" rowspan="1" colspan="1">1.01 (0.83-1.23)</td><td valign="top" align="left" rowspan="1" colspan="1">.92</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Positive interpersonal relationships</td><td valign="top" align="left" rowspan="1" colspan="1">1.52 (0.98-2.35)</td><td valign="top" align="left" rowspan="1" colspan="1">.06</td><td valign="top" align="left" rowspan="1" colspan="1">1.14 (0.94-1.39)</td><td valign="top" align="left" rowspan="1" colspan="1">.18</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Significant other</td><td valign="top" align="left" rowspan="1" colspan="1">0.88 (0.50-1.53)</td><td valign="top" align="left" rowspan="1" colspan="1">.64</td><td valign="top" align="left" rowspan="1" colspan="1">1.15 (0.87-1.51)</td><td valign="top" align="left" rowspan="1" colspan="1">.32</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Caregiving responsibilities</td><td valign="top" align="left" rowspan="1" colspan="1">1.08 (0.59-1.98)</td><td valign="top" align="left" rowspan="1" colspan="1">.80</td><td valign="top" align="left" rowspan="1" colspan="1">0.87 (0.65-1.17)</td><td valign="top" align="left" rowspan="1" colspan="1">.35</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hope for the future</td><td valign="top" align="left" rowspan="1" colspan="1">1.18 (0.78-1.79)</td><td valign="top" align="left" rowspan="1" colspan="1">.44</td><td valign="top" align="left" rowspan="1" colspan="1">1.10 (0.91-1.32)</td><td valign="top" align="left" rowspan="1" colspan="1">.34</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Personal traits or beliefs against suicide</td><td valign="top" align="left" rowspan="1" colspan="1">1.03 (0.66-1.59)</td><td valign="top" align="left" rowspan="1" colspan="1">.90</td><td valign="top" align="left" rowspan="1" colspan="1">0.81 (0.67-0.99)<xref rid="zoi241712t3n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">.04</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Religious beliefs against suicide</td><td valign="top" align="left" rowspan="1" colspan="1">0.81 (0.48-1.37)</td><td valign="top" align="left" rowspan="1" colspan="1">.44</td><td valign="top" align="left" rowspan="1" colspan="1">0.92 (0.71-1.17)</td><td valign="top" align="left" rowspan="1" colspan="1">.48</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Cultural connections</td><td valign="top" align="left" rowspan="1" colspan="1">1.02 (0.58-1.80)</td><td valign="top" align="left" rowspan="1" colspan="1">.94</td><td valign="top" align="left" rowspan="1" colspan="1">0.84 (0.61-1.17)</td><td valign="top" align="left" rowspan="1" colspan="1">.30</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Social support</td><td valign="top" align="left" rowspan="1" colspan="1">0.94 (0.64-1.39)</td><td valign="top" align="left" rowspan="1" colspan="1">.76</td><td valign="top" align="left" rowspan="1" colspan="1">0.95 (0.77-1.17)</td><td valign="top" align="left" rowspan="1" colspan="1">.62</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Desire to live</td><td valign="top" align="left" rowspan="1" colspan="1">1.20 (0.74-1.93)</td><td valign="top" align="left" rowspan="1" colspan="1">.47</td><td valign="top" align="left" rowspan="1" colspan="1">1.02 (0.83-1.26)</td><td valign="top" align="left" rowspan="1" colspan="1">.87</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other</td><td valign="top" align="left" rowspan="1" colspan="1">1.13 (0.57-2.25)</td><td valign="top" align="left" rowspan="1" colspan="1">.73</td><td valign="top" align="left" rowspan="1" colspan="1">1.20 (0.83-1.74)</td><td valign="top" align="left" rowspan="1" colspan="1">.33</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Acute suicide risk</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> High </td><td valign="top" align="left" rowspan="1" colspan="1">1.18 (0.60-2.35)</td><td valign="top" align="left" rowspan="1" colspan="1">.63</td><td valign="top" align="left" rowspan="1" colspan="1">1.27 (0.92-1.75)</td><td valign="top" align="left" rowspan="1" colspan="1">.15</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Intermediate </td><td valign="top" align="left" rowspan="1" colspan="1">1.19 (0.77-1.84)</td><td valign="top" align="left" rowspan="1" colspan="1">.45</td><td valign="top" align="left" rowspan="1" colspan="1">1.39 (1.13-1.71)</td><td valign="top" align="left" rowspan="1" colspan="1">.002</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Low</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Chronic suicide risk</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> High </td><td valign="top" align="left" rowspan="1" colspan="1">1.88 (0.92-3.85)</td><td valign="top" align="left" rowspan="1" colspan="1">.08</td><td valign="top" align="left" rowspan="1" colspan="1">1.74 (1.22-2.47)</td><td valign="top" align="left" rowspan="1" colspan="1">.002</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Intermediate </td><td valign="top" align="left" rowspan="1" colspan="1">1.32 (0.76-2.30)</td><td valign="top" align="left" rowspan="1" colspan="1">.32</td><td valign="top" align="left" rowspan="1" colspan="1">1.34 (1.01-1.77)</td><td valign="top" align="left" rowspan="1" colspan="1">.04</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Low</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">1 [Reference]</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: AUD, alcohol use disorder; CSRE, comprehensive suicide risk evaluation; ED, emergency department; HR, hazard ratio; IP, inpatient; MH, mental health; MHC, mental health clinic; NA, not applicable; OP, outpatient; PCMHI, primary care&#x02013;mental health integration; PTSD, posttraumatic stress disorder; SUD, substance use disorder.</p><fn id="zoi241712t3n1"><label>
<sup>a</sup>
</label><p>Effect did not meet criteria for being statistically and clinically significant (ie, HR &#x02264;0.77 or &#x02265;1.30 [<italic>P</italic>&#x02009;&#x02264;&#x02009;.05]).</p></fn><fn id="zoi241712t3n2"><label>
<sup>b</sup>
</label><p>Effect estimates based on cell sizes of less than 10 patients are suppressed per privacy guidelines.</p></fn></table-wrap-foot></table-wrap></sec><sec id="H2-6-ZOI241712"><title>Suicide in the 365 Days After CSRE Administration</title><p>Suicidal ideation (HR,&#x02009;1.63; 95% CI, 1.20-2.21) (<xref rid="zoi241712t3" ref-type="table">Table 3</xref>), firearm access (HR,&#x02009;1.55; 95% CI, 1.13-2.13), direct suicide preparations (HR,&#x02009;1.56; 95% CI, 1.09-2.23), reckless behaviors (HR,&#x02009;1.40; 95% CI, 1.00-1.95]), and history of psychiatric hospitalization (HR,&#x02009;1.68; 95% CI, 1.32-2.13) were associated with a significantly increased suicide risk in the 365 days following CSRE administration after controlling for demographic factors, setting, and psychiatric diagnoses, whereas anger (HR,&#x02009;0.56; 95% CI, 0.44-0.71), preexisting risk factors (eg, trauma; HR,&#x02009;0.77; 95% CI, 0.62-0.96), and recent transition from the military (HR,&#x02009;0.39; 95% CI, 0.22-0.70) were associated with decreased suicide risk. Clinician-reported risk assessment ratings associated with increased suicide risk were intermediate acute risk (HR,&#x02009;1.39; 95% CI, 1.13-1.71), intermediate chronic risk (HR,&#x02009;1.34; 95% CI, 1.01-1.77), and high chronic risk (HR,&#x02009;1.74; 95% CI, 1.22-2.47), compared with low risk.</p></sec></sec><sec id="H1-4-ZOI241712"><title>Discussion</title><p>Models of the 43 constructs included in the nationally standardized VHA CSRE identified only 4 that found clinically and statistically significant associations with suicide within both 30 days and 365 days. These constructs include suicidal ideation, firearm access, and preparatory behaviors as risk factors, whereas anger was unexpectedly associated with reduced risk. The CSRE includes 14 constructs it identifies as protective factors, yet none of these factors were associated with suicide in adjusted models. Taken together, findings indicate that a narrow set of risk factors&#x02014;namely access and preparations to use lethal means&#x02014;are most critical when assessing acute and chronic suicide risk; in the presence of these risk factors, previously identified protective factors may be insufficient to prevent suicide.</p><p>Anxiety was additionally associated with suicide within 30 days of a CSRE, which is consistent with studies of acute warning signs of suicide attempts<sup><xref rid="zoi241712r15" ref-type="bibr">15</xref>,<xref rid="zoi241712r16" ref-type="bibr">16</xref></sup> and negative reinforcement models of suicide.<sup><xref rid="zoi241712r17" ref-type="bibr">17</xref>,<xref rid="zoi241712r18" ref-type="bibr">18</xref></sup> Reckless behaviors were also associated with suicide within 365 days, as consistent with extant research.<sup><xref rid="zoi241712r19" ref-type="bibr">19</xref></sup> Prior studies also reported alcohol use as a warning sign for suicide attempts,<sup><xref rid="zoi241712r15" ref-type="bibr">15</xref>,<xref rid="zoi241712r20" ref-type="bibr">20</xref>,<xref rid="zoi241712r21" ref-type="bibr">21</xref></sup> whereas substance use (including alcohol) on the CSRE was not associated with suicide. This contrast in findings could be due to the CSRE not isolating alcohol-specific risk or could reflect differences in warning signs for suicide attempts vs suicide. Prior studies also identified interpersonal negative life events, perceived burdensomeness, and emptiness as warning signs for suicide attempts<sup><xref rid="zoi241712r15" ref-type="bibr">15</xref></sup>; however, the CSRE does not explicitly include these domains.</p><p>Firearm access had a consistent positive association with suicide across all risk periods. Among veterans, firearm suicide rates exceed all other method-specific rates.<sup><xref rid="zoi241712r1" ref-type="bibr">1</xref></sup> The VHA has invested in interventions to limit firearm access during suicide crises, such as distributing gun locks.<sup><xref rid="zoi241712r4" ref-type="bibr">4</xref></sup> However, veterans who died by suicide via firearms are less likely to have received lethal means safety counseling and had lower levels of suicide risk factors (eg, prior suicide attempts),<sup><xref rid="zoi241712r22" ref-type="bibr">22</xref></sup> potentially due to the high lethality of firearms,<sup><xref rid="zoi241712r23" ref-type="bibr">23</xref>,<xref rid="zoi241712r24" ref-type="bibr">24</xref>,<xref rid="zoi241712r25" ref-type="bibr">25</xref></sup> indicating that they may be less likely to receive safety counseling. The consistency of these findings underscores the importance of reducing firearm access during suicide crises and expanding access to lethal means safety interventions.<sup><xref rid="zoi241712r26" ref-type="bibr">26</xref>,<xref rid="zoi241712r27" ref-type="bibr">27</xref></sup></p><p>The CSRE includes 14 identified protective factors, yet none were associated with suicide in adjusted models. Protective factors for suicide attempts have been identified among veterans,<sup><xref rid="zoi241712r28" ref-type="bibr">28</xref>,<xref rid="zoi241712r29" ref-type="bibr">29</xref>,<xref rid="zoi241712r30" ref-type="bibr">30</xref></sup> such as social support. However, protective factors for suicide likely differ from suicide attempts, with literature suggesting social disconnection may protect against suicide attempts but not suicide.<sup><xref rid="zoi241712r31" ref-type="bibr">31</xref></sup> Research is needed to determine whether protective factors in the CSRE are associated with suicide attempts to support their continued inclusion in the CSRE and inform policies, such as The Joint Commission&#x02019;s National Patient Safety Goals, that require an assessment of protective factors.<sup><xref rid="zoi241712r7" ref-type="bibr">7</xref></sup></p><p>Although 24 of the 43 CSRE constructs (55.81%) were associated with suicide in bivariate analyses, only 10 (23.26%) were associated with acute or chronic suicide risk in adjusted models. Clinicians report concern regarding the time required to conduct the CSRE.<sup><xref rid="zoi241712r32" ref-type="bibr">32</xref></sup> Reducing the CSRE to include only constructs associated with suicide or other relevant outcomes (eg, suicide attempts, hospitalization) could reduce patient and clinician burden, which may be particularly salient given competing demands during suicide crises.</p><p>Although assessments of intermediate acute and intermediate to high chronic risk were associated with suicide within 365 days, no clinician risk determinations were associated with suicide within 30 days in adjusted models. Additionally, 172 CSREs for 133 unique suicide decedents were assessed as being at low acute and low chronic risk. These findings suggest clinician judgments informed by the CSRE are imperfect predictive factors associated with suicide. This could be due to clinicians undervaluing risk factors like firearm access or overvaluing constructs with null associations with suicide during risk determinations. Research should explore which constructs are associated with suicide vs clinician risk determinations to identify potential opportunities for clinician education. Algorithmic feedback based on CSRE responses may hold promise for improving decision making for frontline providers.</p><p>There were unexpected findings. We found decreased chronic suicide risk for patients with anger, preexisting risk factors, and a recent transition from the military. Studies have found these constructs to be associated with increased suicide risk and related outcomes.<sup><xref rid="zoi241712r33" ref-type="bibr">33</xref>,<xref rid="zoi241712r34" ref-type="bibr">34</xref>,<xref rid="zoi241712r35" ref-type="bibr">35</xref>,<xref rid="zoi241712r36" ref-type="bibr">36</xref></sup> In the VHA, anger is commonly associated with posttraumatic stress disorder (PTSD),<sup><xref rid="zoi241712r37" ref-type="bibr">37</xref>,<xref rid="zoi241712r38" ref-type="bibr">38</xref>,<xref rid="zoi241712r39" ref-type="bibr">39</xref></sup> and PTSD diagnoses were associated with decreased chronic suicide risk in this study. The VHA has implemented a national rollout of evidence-based PTSD treatments,<sup><xref rid="zoi241712r40" ref-type="bibr">40</xref></sup> and initiating evidence-based PTSD treatment is associated with reduced suicide risk in VHA.<sup><xref rid="zoi241712r41" ref-type="bibr">41</xref></sup> Treatment receipt following the CSRE could influence the association between anger and suicide, and future studies should consider PTSD diagnosis and treatment as possible moderators. Further, preexisting risk factors were associated with reduced suicide risk. The broad nature of this construct, combined with limited CSRE guidance (currently, the only examples are trauma and history of suicide attempt) suggests this association should be interpreted with caution. Finally, this study found reduced suicide risk associated with recent transition from the military. This is inconsistent with literature that identified the period following military separation as a &#x0201c;deadly gap&#x0201d; where former service members are at increased suicide risk.<sup><xref rid="zoi241712r33" ref-type="bibr">33</xref></sup> However, studies have typically included all US military personal,<sup><xref rid="zoi241712r42" ref-type="bibr">42</xref></sup> rather than those engaged in VHA care. Given that health care disruptions may contribute to this high-risk period,<sup><xref rid="zoi241712r43" ref-type="bibr">43</xref></sup> reduced suicide risk observed herein may be due to early engagement in VHA care.</p><sec id="H2-7-ZOI241712"><title>Limitations</title><p>This study has limitations. Conclusions about association between specific constructs and suicide are limited by the lack of standardized prompts and nonspecific nature of constructs included in the CSRE. For example, recent stressors could include myriad types of stressors. Therefore, CSRE responses should be interpreted as clinician-identified markers, rather than standardized items. Further, the CSRE may be improved by including constructs with strong evidence for predictive factors associated with suicidal ideation and behavior (eg, perceived burdensomeness<sup><xref rid="zoi241712r15" ref-type="bibr">15</xref>,<xref rid="zoi241712r44" ref-type="bibr">44</xref>,<xref rid="zoi241712r45" ref-type="bibr">45</xref>,<xref rid="zoi241712r46" ref-type="bibr">46</xref></sup>), or refining broad constructs such as substance use, where evidence suggests substance class is differentially associated with suicidal behavior.<sup><xref rid="zoi241712r47" ref-type="bibr">47</xref></sup> Notably, the CSRE is an evaluation tool designed to guide clinical assessment, not a validated risk prediction instrument, and these findings highlight the challenges of translating clinical evaluations into accurate suicide risk prediction. When interpreting findings, it is important to remember that the CSRE is only administered to a subset of VHA patients, likely those identified as at high risk. Highlighting the nonrepresentative nature of this sample, the unadjusted suicide rate per 100&#x02009;000 person-years for initial CSREs was 228.92, far surpassing the Veteran suicide rate of 33.9.<sup><xref rid="zoi241712r1" ref-type="bibr">1</xref></sup> Therefore, results from this cohort may not extend to the overall VHA patient population or to populations outside VHA, and factors not associated with suicide among those who completed CSREs may still be associated with suicide in other populations. Additionally, this study used death certificate data, which may not capture all suicides.<sup><xref rid="zoi241712r48" ref-type="bibr">48</xref></sup> Further, it is possible that certain risk factors were underreported due to stigma or desire to avoid possible consequences (eg, hospitalization).<sup><xref rid="zoi241712r49" ref-type="bibr">49</xref>,<xref rid="zoi241712r50" ref-type="bibr">50</xref></sup> Last, analyses were potentially confounded by subsequent treatment receipt, with patients identified as at high risk potentially being more likely to receive higher-care intensity, including hospitalization where access to lethal means is highly restricted. It may be that CSRE responses that were unexpectedly associated with decreased suicide risk also contributed to patients being identified as at high risk and receiving more intensive treatment.</p></sec></sec><sec id="H1-5-ZOI241712"><title>Conclusions</title><p>This cohort study provides, to our knowledge, the first national data regarding suicide among VHA patients following CSRE administration. Models of acute (within 30 days) and chronic (within 365 days) suicide risk highlight constructs that may be most relevant for clinical assessment of both short- and long-term risk of suicide. Further, the protective factors included in the CSRE were not associated with suicide, suggesting CSRE refinements may be warranted to minimize patient and clinician burden during suicide crises. Findings suggest VHA clinicians may benefit from a focus on a subset of CSRE responses when evaluating suicide risk. Refining the CSRE to focus on factors with the strongest associations with suicide, standardizing construct definitions, and developing risk prediction algorithms could potentially enhance clinical evaluation.</p></sec></body><back><ref-list id="REF-ZOI241712"><title>References</title><ref id="zoi241712r1"><label>1</label><mixed-citation publication-type="webpage"><person-group><collab>US Dept of Veterans Affairs</collab></person-group>. 2023 National veteran suicide prevention annual report. Office of Mental Health and Suicide Prevention. <year>2023</year>. Updated December 19, 2024. Accessed December 21, 2024. <ext-link xlink:href="https://www.mentalhealth.va.gov/suicide_prevention/data.asp" ext-link-type="uri">https://www.mentalhealth.va.gov/suicide_prevention/data.asp</ext-link></mixed-citation></ref><ref id="zoi241712r2"><label>2</label><mixed-citation publication-type="webpage"><person-group><collab>US Dept of Veterans Affairs</collab></person-group>. Planning and performance management. Fiscal years 2022-28 strategic plan. <year>2022</year>. Accessed April 3, 2023. <ext-link xlink:href="https://department.va.gov/administrations-and-offices/enterprise-integration/planning-and-performance-management/" ext-link-type="uri">https://department.va.gov/administrations-and-offices/enterprise-integration/planning-and-performance-management/</ext-link></mixed-citation></ref><ref id="zoi241712r3"><label>3</label><mixed-citation publication-type="webpage"><person-group><collab>Suicide Prevention Resource Center</collab></person-group>. A Comprehensive approach to suicide prevention. University of Oklahoma. Accessed November 27, 2024. <ext-link xlink:href="https://sprc.org/effective-prevention/comprehensive-approach" ext-link-type="uri">https://sprc.org/effective-prevention/comprehensive-approach</ext-link></mixed-citation></ref><ref id="zoi241712r4"><label>4</label><mixed-citation publication-type="book"><person-group><collab>Dept of Veterans Affairs and Dept of Defense</collab></person-group>. <source>VA/DoD Clinical Practice Guideline for the Assessment and Management of Patients at Risk for Suicide (Version 2.0)</source>. <publisher-name>Dept of Veterans Affairs, Dept of Defense</publisher-name>; <year>2019</year>.</mixed-citation></ref><ref id="zoi241712r5"><label>5</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Posner</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Brown</surname>
<given-names>GK</given-names></string-name>, <string-name><surname>Stanley</surname>
<given-names>B</given-names></string-name>, <etal/></person-group>. <article-title>The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults</article-title>. <source>Am J Psychiatry</source>. <year>2011</year>;<volume>168</volume>(<issue>12</issue>):<fpage>1266</fpage>-<lpage>1277</lpage>. doi:<pub-id pub-id-type="doi">10.1176/appi.ajp.2011.10111704</pub-id>
<pub-id pub-id-type="pmid">22193671</pub-id>
</mixed-citation></ref><ref id="zoi241712r6"><label>6</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Bahraini</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Brenner</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Barry</surname>
<given-names>C</given-names></string-name>, <etal/></person-group>. <article-title>Assessment of rates of suicide risk screening and prevalence of positive screening results among US veterans after implementation of the Veterans Affairs Suicide Risk Identification Strategy</article-title>. <source>JAMA Netw Open</source>. <year>2020</year>;<volume>3</volume>(<issue>10</issue>):<elocation-id>e2022531</elocation-id>. doi:<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.22531</pub-id>
<pub-id pub-id-type="pmid">33084900</pub-id>
</mixed-citation></ref><ref id="zoi241712r7"><label>7</label><mixed-citation publication-type="webpage"><person-group><collab>Joint Commission</collab></person-group>. National Patient Safety Goal for Suicide Prevention: R3 Report. Joint Commission; 1-5. Accessed February 2, 2021. <ext-link xlink:href="https://www.jointcommission.org/standards/r3-report/r3-report-issue-18-national-patient-safety-goal-for-suicide-prevention/" ext-link-type="uri">https://www.jointcommission.org/standards/r3-report/r3-report-issue-18-national-patient-safety-goal-for-suicide-prevention/</ext-link></mixed-citation></ref><ref id="zoi241712r8"><label>8</label><mixed-citation publication-type="webpage"><person-group><collab>Dept of Veterans Affairs, Office of Mental Health and Suicide Prevention</collab></person-group>. Joint Department of Veterans Affairs and Department of Defense mortality data repository. Data compiled from the National Death Index. Updated February 26, <year>2024</year>. Accessed February 16, 2023. <ext-link xlink:href="https://www.mirecc.va.gov/suicideprevention/Data/data_index.asp" ext-link-type="uri">https://www.mirecc.va.gov/suicideprevention/Data/data_index.asp</ext-link></mixed-citation></ref><ref id="zoi241712r9"><label>9</label><mixed-citation publication-type="book"><person-group><collab>World Health Organization</collab></person-group>. <source>International Statistical Classification of Diseases, Tenth Revision (ICD-10).</source>
<publisher-name>World Health Organization</publisher-name>; <year>1992</year>.</mixed-citation></ref><ref id="zoi241712r10"><label>10</label><mixed-citation publication-type="webpage"><person-group><collab>SAS Institute Inc</collab></person-group>. SAS. Version 9.4 M8 Help and Documentation. SAS Institute Inc; <year>2023</year>. Accessed December 30, 2023. <ext-link xlink:href="https://www.sas.com/en_us/home.html" ext-link-type="uri">https://www.sas.com/en_us/home.html</ext-link></mixed-citation></ref><ref id="zoi241712r11"><label>11</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Louzon</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Bossarte</surname>
<given-names>R</given-names></string-name>, <string-name><surname>McCarthy</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Katz</surname>
<given-names>IR</given-names></string-name></person-group>. <article-title>Does suicidal ideation as measured by the PHQ-9 predict suicide among VA patients?</article-title>
<source>Psychiatr Serv</source>. <year>2016</year>;<volume>67</volume>(<issue>5</issue>):<fpage>517</fpage>-<lpage>522</lpage>. doi:<pub-id pub-id-type="doi">10.1176/appi.ps.201500149</pub-id>
<pub-id pub-id-type="pmid">26766757</pub-id>
</mixed-citation></ref><ref id="zoi241712r12"><label>12</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Cooper</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Szymanski</surname>
<given-names>BR</given-names></string-name>, <string-name><surname>Bohnert</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Sripada</surname>
<given-names>RK</given-names></string-name>, <string-name><surname>McCarthy</surname>
<given-names>JF</given-names></string-name></person-group>. <article-title>Association between positive results on the primary care-posttraumatic stress disorder screen and suicide mortality among US veterans</article-title>. <source>JAMA Netw Open</source>. <year>2020</year>;<volume>3</volume>(<issue>9</issue>):<elocation-id>e2015707</elocation-id>. doi:<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.15707</pub-id>
<pub-id pub-id-type="pmid">32880649</pub-id>
</mixed-citation></ref><ref id="zoi241712r13"><label>13</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Senaviratna</surname>
<given-names>NAMR</given-names></string-name>, <string-name><surname>Cooray</surname>
<given-names>TMJA</given-names></string-name></person-group>. <article-title>Diagnosing multicollinearity of logistic regression model</article-title>. <source>Asian J Probab Stat.</source>
<year>2019</year>;<volume>5</volume>(<issue>2</issue>):<fpage>1</fpage>-<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.9734/ajpas/2019/v5i230132</pub-id>
</mixed-citation></ref><ref id="zoi241712r14"><label>14</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Azuero</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>A note on the magnitude of hazard ratios</article-title>. <source>Cancer</source>. <year>2016</year>;<volume>122</volume>(<issue>8</issue>):<fpage>1298</fpage>-<lpage>1299</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cncr.29924</pub-id>
<pub-id pub-id-type="pmid">26882217</pub-id>
</mixed-citation></ref><ref id="zoi241712r15"><label>15</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Bagge</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Littlefield</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Wiegand</surname>
<given-names>TJ</given-names></string-name>, <etal/></person-group>. <article-title>A controlled examination of acute warning signs for suicide attempts among hospitalized patients</article-title>. <source>Psychol Med</source>. <year>2023</year>;<volume>53</volume>(<issue>7</issue>):<fpage>2768</fpage>-<lpage>2776</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S0033291721004712</pub-id>
<pub-id pub-id-type="pmid">35074021</pub-id>
</mixed-citation></ref><ref id="zoi241712r16"><label>16</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Tsai</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Klonsky</surname>
<given-names>ED</given-names></string-name></person-group>. <article-title>Warning signs for suicide attempts in psychiatric inpatients: patient and informant perspectives</article-title>. <source>Gen Hosp Psychiatry</source>. <year>2023</year>;<volume>85</volume>:<fpage>207</fpage>-<lpage>212</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.genhosppsych.2023.11.005</pub-id>
<pub-id pub-id-type="pmid">37979471</pub-id>
</mixed-citation></ref><ref id="zoi241712r17"><label>17</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Shneidman</surname>
<given-names>ES</given-names></string-name></person-group>. <article-title>Suicide as psychache</article-title>. <source>J Nerv Ment Dis</source>. <year>1993</year>;<volume>181</volume>(<issue>3</issue>):<fpage>145</fpage>-<lpage>147</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00005053-199303000-00001</pub-id>
<pub-id pub-id-type="pmid">8445372</pub-id>
</mixed-citation></ref><ref id="zoi241712r18"><label>18</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Allan</surname>
<given-names>NP</given-names></string-name>, <string-name><surname>Gorka</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Saulnier</surname>
<given-names>KG</given-names></string-name>, <string-name><surname>Bryan</surname>
<given-names>CJ</given-names></string-name></person-group>. <article-title>Anxiety sensitivity and intolerance of uncertainty: transdiagnostic risk factors for anxiety as targets to reduce risk of suicide</article-title>. <source>Curr Psychiatry Rep</source>. <year>2023</year>;<volume>25</volume>(<issue>4</issue>):<fpage>139</fpage>-<lpage>147</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11920-023-01413-z</pub-id>
<pub-id pub-id-type="pmid">37000403</pub-id>
</mixed-citation></ref><ref id="zoi241712r19"><label>19</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Athey</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Overholser</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bagge</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Dieter</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Vallender</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Stockmeier</surname>
<given-names>CA</given-names></string-name></person-group>. <article-title>Risk-taking behaviors and stressors differentially predict suicidal preparation, non-fatal suicide attempts, and suicide deaths</article-title>. <source>Psychiatry Res</source>. <year>2018</year>;<volume>270</volume>:<fpage>160</fpage>-<lpage>167</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.psychres.2018.09.032</pub-id>
<pub-id pub-id-type="pmid">30253320</pub-id>
</mixed-citation></ref><ref id="zoi241712r20"><label>20</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Bagge</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Schumacher</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Gratz</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Krull</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Holloman</surname>
<given-names>G</given-names>
<suffix>Jr</suffix></string-name></person-group>. <article-title>Alcohol as an acute risk factor for recent suicide attempts: a case-crossover analysis</article-title>. <source>J Stud Alcohol Drugs</source>. <year>2013</year>;<volume>74</volume>(<issue>4</issue>):<fpage>552</fpage>-<lpage>558</lpage>. doi:<pub-id pub-id-type="doi">10.15288/jsad.2013.74.552</pub-id>
<pub-id pub-id-type="pmid">23739018</pub-id>
</mixed-citation></ref><ref id="zoi241712r21"><label>21</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Hufford</surname>
<given-names>MR</given-names></string-name></person-group>. <article-title>Alcohol and suicidal behavior</article-title>. <source>Clin Psychol Rev</source>. <year>2001</year>;<volume>21</volume>(<issue>5</issue>):<fpage>797</fpage>-<lpage>811</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0272-7358(00)00070-2</pub-id>
<pub-id pub-id-type="pmid">11434231</pub-id>
</mixed-citation></ref><ref id="zoi241712r22"><label>22</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Ammerman</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Reger</surname>
<given-names>MA</given-names></string-name></person-group>. <article-title>Evaluation of prevention efforts and risk factors among veteran suicide decedents who died by firearm</article-title>. <source>Suicide Life Threat Behav</source>. <year>2020</year>;<volume>50</volume>(<issue>3</issue>):<fpage>679</fpage>-<lpage>687</lpage>. doi:<pub-id pub-id-type="doi">10.1111/sltb.12618</pub-id>
<pub-id pub-id-type="pmid">32017233</pub-id>
</mixed-citation></ref><ref id="zoi241712r23"><label>23</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Liotta</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mento</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Settineri</surname>
<given-names>S</given-names></string-name></person-group>. <article-title>Seriousness and lethality of attempted suicide: a SYSTEMATIC review</article-title>. <source>Aggress Violent Behav</source>. <year>2015</year>;<volume>21</volume>:<fpage>97</fpage>-<lpage>109</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.avb.2014.12.013</pub-id>
</mixed-citation></ref><ref id="zoi241712r24"><label>24</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Shenassa</surname>
<given-names>ED</given-names></string-name>, <string-name><surname>Catlin</surname>
<given-names>SN</given-names></string-name>, <string-name><surname>Buka</surname>
<given-names>SL</given-names></string-name></person-group>. <article-title>Lethality of firearms relative to other suicide methods: a population based study</article-title>. <source>J Epidemiol Community Health</source>. <year>2003</year>;<volume>57</volume>(<issue>2</issue>):<fpage>120</fpage>-<lpage>124</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jech.57.2.120</pub-id>
<pub-id pub-id-type="pmid">12540687</pub-id>
</mixed-citation></ref><ref id="zoi241712r25"><label>25</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Wang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Sumner</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Simon</surname>
<given-names>TR</given-names></string-name>, <etal/></person-group>. <article-title>Trends in the incidence and lethality of suicidal acts in the United States, 2006 to 2015</article-title>. <source>JAMA Psychiatry</source>. <year>2020</year>;<volume>77</volume>(<issue>7</issue>):<fpage>684</fpage>-<lpage>693</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2020.0596</pub-id>
<pub-id pub-id-type="pmid">32320023</pub-id>
</mixed-citation></ref><ref id="zoi241712r26"><label>26</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Betz</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Thomas</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Simonetti</surname>
<given-names>JA</given-names></string-name></person-group>. <article-title>Firearms, suicide, and approaches for prevention</article-title>. <source>JAMA</source>. <year>2022</year>;<volume>328</volume>(<issue>12</issue>):<fpage>1179</fpage>-<lpage>1180</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2022.16663</pub-id>
<pub-id pub-id-type="pmid">36166015</pub-id>
</mixed-citation></ref><ref id="zoi241712r27"><label>27</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Pallin</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Barnhorst</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>Clinical strategies for reducing firearm suicide</article-title>. <source>Inj Epidemiol</source>. <year>2021</year>;<volume>8</volume>(<issue>1</issue>):<fpage>57</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s40621-021-00352-8</pub-id>
<pub-id pub-id-type="pmid">34607607</pub-id>
</mixed-citation></ref><ref id="zoi241712r28"><label>28</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Fischer</surname>
<given-names>IC</given-names></string-name>, <string-name><surname>Nichter</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Feldman</surname>
<given-names>DB</given-names></string-name>, <etal/></person-group>. <article-title>Purpose in life protects against the development of suicidal thoughts and behaviors in US veterans without a history of suicidality: a 10-year, nationally representative, longitudinal study</article-title>. <source>J Affect Disord</source>. <year>2023</year>;<volume>340</volume>:<fpage>551</fpage>-<lpage>554</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jad.2023.08.040</pub-id>
<pub-id pub-id-type="pmid">37557988</pub-id>
</mixed-citation></ref><ref id="zoi241712r29"><label>29</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Herzog</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Nichter</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Hill</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Norman</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>Pietrzak</surname>
<given-names>RH</given-names></string-name></person-group>. <article-title>Factors associated with remission of suicidal thoughts and behaviors in US military veterans with a history of suicide attempt</article-title>. <source>J Psychiatr Res</source>. <year>2022</year>;<volume>149</volume>:<fpage>62</fpage>-<lpage>67</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpsychires.2022.02.021</pub-id>
<pub-id pub-id-type="pmid">35247722</pub-id>
</mixed-citation></ref><ref id="zoi241712r30"><label>30</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Nichter</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Stein</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>Monteith</surname>
<given-names>LL</given-names></string-name>, <etal/></person-group>. <article-title>Risk factors for suicide attempts among US military veterans: a 7-year population-based, longitudinal cohort study</article-title>. <source>Suicide Life Threat Behav</source>. <year>2022</year>;<volume>52</volume>(<issue>2</issue>):<fpage>303</fpage>-<lpage>316</lpage>. doi:<pub-id pub-id-type="doi">10.1111/sltb.12822</pub-id>
<pub-id pub-id-type="pmid">34873738</pub-id>
</mixed-citation></ref><ref id="zoi241712r31"><label>31</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Beautrais</surname>
<given-names>AL</given-names></string-name></person-group>. <article-title>Suicides and serious suicide attempts: two populations or one?</article-title>
<source>Psychol Med</source>. <year>2001</year>;<volume>31</volume>(<issue>5</issue>):<fpage>837</fpage>-<lpage>845</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S0033291701003889</pub-id>
<pub-id pub-id-type="pmid">11459381</pub-id>
</mixed-citation></ref><ref id="zoi241712r32"><label>32</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Dobscha</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Newell</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>Elliott</surname>
<given-names>VJ</given-names></string-name>, <etal/></person-group>. <article-title>Primary care and mental health staff perspectives on universal suicide risk screening and care coordination</article-title>. <source>Psychiatr Serv</source>. <year>2023</year>;<volume>74</volume>(<issue>3</issue>):<fpage>305</fpage>-<lpage>311</lpage>. doi:<pub-id pub-id-type="doi">10.1176/appi.ps.20220087</pub-id>
<pub-id pub-id-type="pmid">35959535</pub-id>
</mixed-citation></ref><ref id="zoi241712r33"><label>33</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Sokol</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Gromatsky</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Edwards</surname>
<given-names>ER</given-names></string-name>, <etal/></person-group>. <article-title>The deadly gap: understanding suicide among veterans transitioning out of the military</article-title>. <source>Psychiatry Res</source>. <year>2021</year>;<volume>300</volume>:<elocation-id>113875</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.psychres.2021.113875</pub-id>
<pub-id pub-id-type="pmid">33901974</pub-id>
</mixed-citation></ref><ref id="zoi241712r34"><label>34</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Nichter</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Hill</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Norman</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Haller</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Pietrzak</surname>
<given-names>RH</given-names></string-name></person-group>. <article-title>Associations of childhood abuse and combat exposure with suicidal ideation and suicide attempt in US military veterans: a nationally representative study</article-title>. <source>J Affect Disord</source>. <year>2020</year>;<volume>276</volume>:<fpage>1102</fpage>-<lpage>1108</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jad.2020.07.120</pub-id>
<pub-id pub-id-type="pmid">32777648</pub-id>
</mixed-citation></ref><ref id="zoi241712r35"><label>35</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Bryan</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Griffith</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Pace</surname>
<given-names>BT</given-names></string-name>, <etal/></person-group>. <article-title>Combat exposure and risk for suicidal thoughts and behaviors among military personnel and veterans: a systematic review and meta-analysis</article-title>. <source>Suicide Life Threat Behav</source>. <year>2015</year>;<volume>45</volume>(<issue>5</issue>):<fpage>633</fpage>-<lpage>649</lpage>. doi:<pub-id pub-id-type="doi">10.1111/sltb.12163</pub-id>
<pub-id pub-id-type="pmid">29889337</pub-id>
</mixed-citation></ref><ref id="zoi241712r36"><label>36</label><mixed-citation publication-type="journal"><person-group><string-name><surname>McKinney</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Hirsch</surname>
<given-names>JK</given-names></string-name>, <string-name><surname>Britton</surname>
<given-names>PC</given-names></string-name></person-group>. <article-title>PTSD symptoms and suicide risk in veterans: serial indirect effects via depression and anger</article-title>. <source>J Affect Disord</source>. <year>2017</year>;<volume>214</volume>:<fpage>100</fpage>-<lpage>107</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jad.2017.03.008</pub-id>
<pub-id pub-id-type="pmid">28288403</pub-id>
</mixed-citation></ref><ref id="zoi241712r37"><label>37</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Kulkarni</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Porter</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Rauch</surname>
<given-names>SAM</given-names></string-name></person-group>. <article-title>Anger, dissociation, and PTSD among male veterans entering into PTSD treatment</article-title>. <source>J Anxiety Disord</source>. <year>2012</year>;<volume>26</volume>(<issue>2</issue>):<fpage>271</fpage>-<lpage>278</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.janxdis.2011.12.005</pub-id>
<pub-id pub-id-type="pmid">22245698</pub-id>
</mixed-citation></ref><ref id="zoi241712r38"><label>38</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Taft</surname>
<given-names>CT</given-names></string-name>, <string-name><surname>Street</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>Marshall</surname>
<given-names>AD</given-names></string-name>, <string-name><surname>Dowdall</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Riggs</surname>
<given-names>DS</given-names></string-name></person-group>. <article-title>Posttraumatic stress disorder, anger, and partner abuse among Vietnam combat veterans</article-title>. <source>J Fam Psychol</source>. <year>2007</year>;<volume>21</volume>(<issue>2</issue>):<fpage>270</fpage>-<lpage>277</lpage>. doi:<pub-id pub-id-type="doi">10.1037/0893-3200.21.2.270</pub-id>
<pub-id pub-id-type="pmid">17605549</pub-id>
</mixed-citation></ref><ref id="zoi241712r39"><label>39</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Jakupcak</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Conybeare</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Phelps</surname>
<given-names>L</given-names></string-name>, <etal/></person-group>. <article-title>Anger, hostility, and aggression among Iraq and Afghanistan War veterans reporting PTSD and subthreshold PTSD</article-title>. <source>J Trauma Stress</source>. <year>2007</year>;<volume>20</volume>(<issue>6</issue>):<fpage>945</fpage>-<lpage>954</lpage>. doi:<pub-id pub-id-type="doi">10.1002/jts.20258</pub-id>
<pub-id pub-id-type="pmid">18157891</pub-id>
</mixed-citation></ref><ref id="zoi241712r40"><label>40</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Rosen</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Matthieu</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Wiltsey Stirman</surname>
<given-names>S</given-names></string-name>, <etal/></person-group>. <article-title>A review of studies on the system-wide implementation of evidence-based psychotherapies for posttraumatic stress disorder in the Veterans Health Administration</article-title>. <source>Adm Policy Ment Health</source>. <year>2016</year>;<volume>43</volume>(<issue>6</issue>):<fpage>957</fpage>-<lpage>977</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10488-016-0755-0</pub-id>
<pub-id pub-id-type="pmid">27474040</pub-id>
</mixed-citation></ref><ref id="zoi241712r41"><label>41</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Saulnier</surname>
<given-names>KG</given-names></string-name>, <string-name><surname>Brabbs</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Szymanski</surname>
<given-names>BR</given-names></string-name>, <string-name><surname>Harpaz-Rotem</surname>
<given-names>I</given-names></string-name>, <string-name><surname>McCarthy</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Sripada</surname>
<given-names>RK</given-names></string-name></person-group>. <article-title>Suicide risk among veterans who receive evidence-based therapy for posttraumatic stress disorder</article-title>. <source>JAMA Netw Open</source>. <year>2024</year>;<volume>7</volume>(<issue>12</issue>):<elocation-id>e2452144</elocation-id>. doi:<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2024.52144</pub-id><pub-id pub-id-type="pmid">39724372</pub-id>
</mixed-citation></ref><ref id="zoi241712r42"><label>42</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Shen</surname>
<given-names>YC</given-names></string-name>, <string-name><surname>Cunha</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Williams</surname>
<given-names>TV</given-names></string-name></person-group>. <article-title>Time-varying associations of suicide with deployments, mental health conditions, and stressful life events among current and former US military personnel: a retrospective multivariate analysis</article-title>. <source>Lancet Psychiatry</source>. <year>2016</year>;<volume>3</volume>(<issue>11</issue>):<fpage>1039</fpage>-<lpage>1048</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S2215-0366(16)30304-2</pub-id>
<pub-id pub-id-type="pmid">27697514</pub-id>
</mixed-citation></ref><ref id="zoi241712r43"><label>43</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Primack</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Borsari</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Benz</surname>
<given-names>MB</given-names></string-name>, <string-name><surname>Reddy</surname>
<given-names>MK</given-names></string-name>, <string-name><surname>Shea</surname>
<given-names>MT</given-names></string-name></person-group>. <article-title>Mental health treatment utilization in OIF/OEF National Guard and reserve troops with and without DSM diagnoses</article-title>. <source>Am J Orthopsychiatry</source>. <year>2017</year>;<volume>87</volume>(<issue>2</issue>):<fpage>157</fpage>-<lpage>165</lpage>. doi:<pub-id pub-id-type="doi">10.1037/ort0000226</pub-id>
<pub-id pub-id-type="pmid">28206803</pub-id>
</mixed-citation></ref><ref id="zoi241712r44"><label>44</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Chu</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Buchman-Schmitt</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Stanley</surname>
<given-names>IH</given-names></string-name>, <etal/></person-group>. <article-title>The interpersonal theory of suicide: a systematic review and meta-analysis of a decade of cross-national research</article-title>. <source>Psychol Bull</source>. <year>2017</year>;<volume>143</volume>(<issue>12</issue>):<fpage>1313</fpage>-<lpage>1345</lpage>. doi:<pub-id pub-id-type="doi">10.1037/bul0000123</pub-id>
<pub-id pub-id-type="pmid">29072480</pub-id>
</mixed-citation></ref><ref id="zoi241712r45"><label>45</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Saulnier</surname>
<given-names>KG</given-names></string-name>, <string-name><surname>Volarov</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Velimirovi&#x00107;</surname>
<given-names>M</given-names></string-name>, <etal/></person-group>. <article-title>Risk factors of suicidal behaviors in a high-risk longitudinal veteran sample: a network analysis</article-title>. <source>Suicide Life Threat Behav</source>. <year>2023</year>;<volume>53</volume>(<issue>1</issue>):<fpage>4</fpage>-<lpage>15</lpage>. doi:<pub-id pub-id-type="doi">10.1111/sltb.12918</pub-id>
<pub-id pub-id-type="pmid">36029133</pub-id>
</mixed-citation></ref><ref id="zoi241712r46"><label>46</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Allan</surname>
<given-names>NP</given-names></string-name>, <string-name><surname>Gros</surname>
<given-names>DF</given-names></string-name>, <string-name><surname>Lancaster</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Saulnier</surname>
<given-names>KG</given-names></string-name>, <string-name><surname>Stecker</surname>
<given-names>T</given-names></string-name></person-group>. <article-title>Heterogeneity in short-term suicidal ideation trajectories: predictors of and projections to suicidal behavior</article-title>. <source>Suicide Life Threat Behav</source>. <year>2019</year>;<volume>49</volume>(<issue>3</issue>):<fpage>826</fpage>-<lpage>837</lpage>. doi:<pub-id pub-id-type="doi">10.1111/sltb.12480</pub-id>
<pub-id pub-id-type="pmid">29938818</pub-id>
</mixed-citation></ref><ref id="zoi241712r47"><label>47</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Bagge</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Borges</surname>
<given-names>G</given-names></string-name></person-group>. <article-title>Acute substance use as a warning sign for suicide attempts: a case-crossover examination of the 48 hours prior to a recent suicide attempt</article-title>. <source>J Clin Psychiatry</source>. <year>2017</year>;<volume>78</volume>(<issue>6</issue>):<fpage>691</fpage>-<lpage>696</lpage>. doi:<pub-id pub-id-type="doi">10.4088/JCP.15m10541</pub-id>
<pub-id pub-id-type="pmid">28682530</pub-id>
</mixed-citation></ref><ref id="zoi241712r48"><label>48</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Jobes</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Berman</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Josselson</surname>
<given-names>AR</given-names></string-name></person-group>. <article-title>Improving the validity and reliability of medical-legal certifications of suicide</article-title>. <source>Suicide Life Threat Behav</source>. <year>1987</year>;<volume>17</volume>(<issue>4</issue>):<fpage>310</fpage>-<lpage>325</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1943-278X.1987.tb00071.x</pub-id>
<pub-id pub-id-type="pmid">3501180</pub-id>
</mixed-citation></ref><ref id="zoi241712r49"><label>49</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Sudak</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Maxim</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Carpenter</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Suicide and stigma: a review of the literature and personal reflections</article-title>. <source>Acad Psychiatry</source>. <year>2008</year>;<volume>32</volume>(<issue>2</issue>):<fpage>136</fpage>-<lpage>142</lpage>. doi:<pub-id pub-id-type="doi">10.1176/appi.ap.32.2.136</pub-id>
<pub-id pub-id-type="pmid">18349334</pub-id>
</mixed-citation></ref><ref id="zoi241712r50"><label>50</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Anestis</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Mohn</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Dorminey</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Green</surname>
<given-names>BA</given-names></string-name></person-group>. <article-title>Detecting potential underreporting of suicide ideation among U.S. military personnel</article-title>. <source>Suicide Life Threat Behav</source>. <year>2019</year>;<volume>49</volume>(<issue>1</issue>):<fpage>210</fpage>-<lpage>220</lpage>. doi:<pub-id pub-id-type="doi">10.1111/sltb.12425</pub-id>
<pub-id pub-id-type="pmid">29281745</pub-id>
</mixed-citation></ref></ref-list><notes notes-type="supplementary-material" id="note-ZOI241712-1"><supplementary-material id="note-ZOI241712-1-s" position="float" content-type="local-data"><label>Supplement 1.</label><caption><p><bold>eTable 1.</bold> Cox Proportional Hazards Regression Models Examining Associations With Suicide Within 30 and 365 Days of CSRE Administration Without Clinician-Determined Risk Strata (Ns=269 372)</p><p><bold>eTable 2.</bold> Cox Proportional Hazards Regression Models Examining Predictors of Suicide in the Year After CSRE Administrations for Initial CSREs (Ns=153 648)</p><p><bold>eTable 3.</bold> Cox Proportional Hazards Regression Models Examining Predictors of Suicide in the Year After CSRE Administration for CSREs Within 2 Days of a Positive Columbia Suicide Severity Rating Scale Screen (Ns=81 102)</p><p><bold>eTable 4.</bold> Clinician-Determined Risk Strata Combinations and Suicide Following CSRE Receipt (Ns=269 198)</p></caption><media xlink:href="jamanetwopen-e2461559-s001.pdf"/></supplementary-material><supplementary-material position="float" content-type="local-data"><label>Supplement 2.</label><caption><p>
Data Sharing Statement
</p></caption><media xlink:href="jamanetwopen-e2461559-s002.pdf"/></supplementary-material></notes></back></article><!--requester-ID tigray-->